[


  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "下列何者為急性腎損傷（AKI）最常見的原因分類？",
    "options": [
      { "key": "A", "text": "腎前性（prerenal）" },
      { "key": "B", "text": "腎實質性（intrinsic）" },
      { "key": "C", "text": "腎後性（postrenal）" },
      { "key": "D", "text": "免疫性" }
    ],
    "answer": "A",
    "explanation": "臨床上 AKI 最常見為腎前性原因（如低血容量、低灌流），其次才是腎實質性與腎後性。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "下列何者最有助於區分腎前性 AKI 與急性腎小管壞死（ATN）？",
    "options": [
      { "key": "A", "text": "血清鈉濃度" },
      { "key": "B", "text": "尿液鈉濃度與 FENa" },
      { "key": "C", "text": "血紅素" },
      { "key": "D", "text": "血清白蛋白" }
    ],
    "answer": "B",
    "explanation": "腎前性 AKI 通常尿鈉低、FENa <1%；ATN 則尿鈉高、FENa >2%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "關於急性腎小管壞死（ATN），下列何者正確？",
    "options": [
      { "key": "A", "text": "最常由尿路阻塞造成" },
      { "key": "B", "text": "尿沈渣可見泥沙樣（muddy brown）圓柱" },
      { "key": "C", "text": "FENa 通常小於 1%" },
      { "key": "D", "text": "腎功能恢復通常非常迅速" }
    ],
    "answer": "B",
    "explanation": "ATN 常見於缺血或毒性傷害，尿沈渣可見泥沙樣圓柱；FENa 多大於 2%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "急性腎損傷病人出現下列哪一項情況時，最需要考慮緊急透析？",
    "options": [
      { "key": "A", "text": "輕度血尿" },
      { "key": "B", "text": "代謝性酸中毒合併症狀" },
      { "key": "C", "text": "血肌酸酐輕微上升" },
      { "key": "D", "text": "尿量稍減少" }
    ],
    "answer": "B",
    "explanation": "AKI 透析適應症包含難以控制的酸中毒、高鉀、肺水腫、尿毒症狀（AEIOU）。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "慢性腎臟病（CKD）的定義，下列何者正確？",
    "options": [
      { "key": "A", "text": "腎功能異常持續超過 2 週" },
      { "key": "B", "text": "腎功能異常持續超過 1 個月" },
      { "key": "C", "text": "腎功能異常持續超過 3 個月" },
      { "key": "D", "text": "任何一次 eGFR 下降皆屬 CKD" }
    ],
    "answer": "C",
    "explanation": "CKD 定義為腎臟結構或功能異常持續至少 3 個月，且具臨床意義。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "下列何者最常見為慢性腎臟病的病因？",
    "options": [
      { "key": "A", "text": "腎結石" },
      { "key": "B", "text": "糖尿病" },
      { "key": "C", "text": "急性腎炎" },
      { "key": "D", "text": "腎腫瘤" }
    ],
    "answer": "B",
    "explanation": "糖尿病為全球 CKD 與末期腎病最常見原因，其次為高血壓。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "關於 CKD 併發症，下列何者正確？",
    "options": [
      { "key": "A", "text": "低血磷" },
      { "key": "B", "text": "次發性副甲狀腺亢進" },
      { "key": "C", "text": "高血鈣" },
      { "key": "D", "text": "紅血球增多症" }
    ],
    "answer": "B",
    "explanation": "CKD 常見高磷、低鈣與次發性副甲狀腺亢進，並伴隨腎性貧血。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "關於 CKD 病人的用藥原則，下列何者最恰當？",
    "options": [
      { "key": "A", "text": "所有藥物皆可照一般劑量使用" },
      { "key": "B", "text": "需依腎功能調整藥物劑量" },
      { "key": "C", "text": "避免使用所有降壓藥" },
      { "key": "D", "text": "只需注意抗生素" }
    ],
    "answer": "B",
    "explanation": "CKD 病人多數藥物需依 eGFR 調整劑量，以避免藥物蓄積與毒性。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "下列何者為腎病症候群（nephrotic syndrome）的典型表現？",
    "options": [
      { "key": "A", "text": "蛋白尿 < 1 g/day" },
      { "key": "B", "text": "顯著蛋白尿、低白蛋白血症、水腫" },
      { "key": "C", "text": "明顯血尿與 RBC casts" },
      { "key": "D", "text": "低血脂" }
    ],
    "answer": "B",
    "explanation": "腎病症候群以大量蛋白尿（>3.5 g/day）、低白蛋白血症、水腫與高血脂為特徵。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "小兒最常見造成腎病症候群的腎小球疾病為何？",
    "options": [
      { "key": "A", "text": "FSGS" },
      { "key": "B", "text": "Membranous nephropathy" },
      { "key": "C", "text": "Minimal change disease" },
      { "key": "D", "text": "IgA nephropathy" }
    ],
    "answer": "C",
    "explanation": "小兒腎病症候群最常見為 minimal change disease，對類固醇治療反應佳。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "關於 focal segmental glomerulosclerosis（FSGS），下列何者正確？",
    "options": [
      { "key": "A", "text": "多見於兒童，預後佳" },
      { "key": "B", "text": "病灶為所有腎小球均勻受損" },
      { "key": "C", "text": "常與成人腎病症候群相關，預後較差" },
      { "key": "D", "text": "不會進展為末期腎病" }
    ],
    "answer": "C",
    "explanation": "FSGS 多見於成人，部分腎小球與部分節段受損，對治療反應較差，易進展至 CKD。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "腎炎症候群（nephritic syndrome）最具代表性的臨床表現為何？",
    "options": [
      { "key": "A", "text": "大量蛋白尿與高血脂" },
      { "key": "B", "text": "血尿、高血壓、腎功能惡化" },
      { "key": "C", "text": "無症狀蛋白尿" },
      { "key": "D", "text": "低血壓與多尿" }
    ],
    "answer": "B",
    "explanation": "腎炎症候群以血尿、紅血球圓柱、高血壓與腎功能下降為主要特徵。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "IgA 腎病變最典型的臨床表現為何？",
    "options": [
      { "key": "A", "text": "長期無症狀蛋白尿" },
      { "key": "B", "text": "上呼吸道感染後數週出現血尿" },
      { "key": "C", "text": "感染後 1–2 天內出現血尿" },
      { "key": "D", "text": "僅見於老年人" }
    ],
    "answer": "C",
    "explanation": "IgA 腎病變常在上呼吸道感染後短時間內（1–2 天）出現肉眼血尿。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "急性鏈球菌感染後腎炎（PSGN）最常見於下列哪一族群？",
    "options": [
      { "key": "A", "text": "新生兒" },
      { "key": "B", "text": "兒童" },
      { "key": "C", "text": "青壯年" },
      { "key": "D", "text": "老年人" }
    ],
    "answer": "B",
    "explanation": "PSGN 多發生於兒童，常在皮膚或咽喉感染後 1–3 週出現。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_ELECTRO_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜戊 腎因性電解質與酸鹼" },
    "stem": "慢性腎臟病病人最常見的酸鹼異常為何？",
    "options": [
      { "key": "A", "text": "代謝性鹼中毒" },
      { "key": "B", "text": "呼吸性酸中毒" },
      { "key": "C", "text": "代謝性酸中毒" },
      { "key": "D", "text": "呼吸性鹼中毒" }
    ],
    "answer": "C",
    "explanation": "CKD 因酸排泄能力下降，最常見為代謝性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ELECTRO_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜戊 腎因性電解質與酸鹼" },
    "stem": "腎衰竭病人出現高血鉀時，下列何者為最立即的心臟保護處置？",
    "options": [
      { "key": "A", "text": "口服樹脂" },
      { "key": "B", "text": "胰島素合併葡萄糖" },
      { "key": "C", "text": "靜脈注射鈣劑" },
      { "key": "D", "text": "利尿劑" }
    ],
    "answer": "C",
    "explanation": "高血鉀合併心電圖變化時，首要為靜脈注射鈣劑以穩定心肌細胞膜。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_INF_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症" },
    "stem": "下列何者最符合敗血症（sepsis）的定義？",
    "options": [
      { "key": "A", "text": "單純感染合併發燒" },
      { "key": "B", "text": "感染合併器官功能障礙" },
      { "key": "C", "text": "感染合併低血壓且需升壓劑" },
      { "key": "D", "text": "任何血液培養陽性" }
    ],
    "answer": "B",
    "explanation": "Sepsis 定義為感染導致的失調性宿主反應並造成器官功能障礙；C 描述較接近 septic shock。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_INF_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症" },
    "stem": "疑似敗血症病人之初步處置，下列何者最優先？",
    "options": [
      { "key": "A", "text": "等待培養結果再給抗生素" },
      { "key": "B", "text": "立即給予經驗性抗生素並補液" },
      { "key": "C", "text": "先安排影像檢查" },
      { "key": "D", "text": "僅給退燒藥" }
    ],
    "answer": "B",
    "explanation": "敗血症治療核心為及早給予廣效經驗性抗生素與復甦補液，並同時取得培養。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_ABX_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則" },
    "stem": "關於抗生素治療原則，下列何者正確？",
    "options": [
      { "key": "A", "text": "一開始即使用最窄效抗生素" },
      { "key": "B", "text": "培養結果出來後應適度降階（de-escalation）" },
      { "key": "C", "text": "症狀改善即可立刻停藥" },
      { "key": "D", "text": "所有感染療程長度相同" }
    ],
    "answer": "B",
    "explanation": "經驗性治療後，依培養與臨床反應進行降階可降低抗藥性與副作用。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_PNA_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎" },
    "stem": "社區型肺炎（CAP）最常見的致病菌為何？",
    "options": [
      { "key": "A", "text": "Pseudomonas aeruginosa" },
      { "key": "B", "text": "Streptococcus pneumoniae" },
      { "key": "C", "text": "MRSA" },
      { "key": "D", "text": "Candida albicans" }
    ],
    "answer": "B",
    "explanation": "肺炎鏈球菌仍是 CAP 最常見致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PNA_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎" },
    "stem": "下列何者較符合院內型肺炎（HAP）的風險因子？",
    "options": [
      { "key": "A", "text": "未住院的健康成人" },
      { "key": "B", "text": "住院超過 48 小時" },
      { "key": "C", "text": "近期無抗生素使用" },
      { "key": "D", "text": "門診追蹤病人" }
    ],
    "answer": "B",
    "explanation": "HAP 定義為住院 ≥48 小時後發生的肺炎，致病菌與抗藥性風險較高。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染" },
    "stem": "造成社區型泌尿道感染最常見的致病菌為何？",
    "options": [
      { "key": "A", "text": "Enterococcus faecalis" },
      { "key": "B", "text": "Escherichia coli" },
      { "key": "C", "text": "Pseudomonas aeruginosa" },
      { "key": "D", "text": "Staphylococcus aureus" }
    ],
    "answer": "B",
    "explanation": "E. coli 為社區型 UTI 最常見致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染" },
    "stem": "關於單純性膀胱炎的治療，下列何者正確？",
    "options": [
      { "key": "A", "text": "一定需要靜脈抗生素" },
      { "key": "B", "text": "口服抗生素即可，療程較短" },
      { "key": "C", "text": "一律需住院治療" },
      { "key": "D", "text": "不需治療可自癒" }
    ],
    "answer": "B",
    "explanation": "單純性膀胱炎多可門診口服抗生素治療。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚與軟組織感染" },
    "stem": "下列何者最符合壞死性筋膜炎的臨床特徵？",
    "options": [
      { "key": "A", "text": "局部紅腫且疼痛程度與外觀不成比例" },
      { "key": "B", "text": "僅有輕微搔癢" },
      { "key": "C", "text": "慢性反覆發作" },
      { "key": "D", "text": "不影響全身狀態" }
    ],
    "answer": "A",
    "explanation": "壞死性筋膜炎常見「疼痛與外觀不成比例」，需緊急手術與廣效抗生素。"
  },


  {
    "id": "MED3_RENAL_INF_DER_SEPSIS_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症｜初期處置" },
    "stem": "懷疑敗血症（sepsis）時，下列哪一項最符合「第一時間處置」的優先順序？",
    "options": [
      { "key": "A", "text": "先等血液培養結果再給抗生素" },
      { "key": "B", "text": "先做完整影像學檢查再開始治療" },
      { "key": "C", "text": "同時抽培養並盡早給予經驗性抗生素與液體復甦" },
      { "key": "D", "text": "只有發燒才需要抗生素" }
    ],
    "answer": "C",
    "explanation": "敗血症的關鍵是「及早復甦＋及早抗生素＋同時做培養」。等待培養或延後治療會增加死亡風險；影像可協助找感染源但不應延誤初始治療。"
  },
  {
    "id": "MED3_RENAL_INF_DER_SEPSIS_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症｜敗血性休克" },
    "stem": "下列哪一項最符合敗血性休克（septic shock）的臨床概念？",
    "options": [
      { "key": "A", "text": "任何血液培養陽性皆為 septic shock" },
      { "key": "B", "text": "感染造成器官功能障礙，但血壓可維持" },
      { "key": "C", "text": "感染合併循環衰竭，充分補液後仍需升壓劑維持灌流" },
      { "key": "D", "text": "只有發燒與白血球上升" }
    ],
    "answer": "C",
    "explanation": "Sepsis 是感染合併器官功能障礙；septic shock 是更嚴重的循環/代謝異常狀態，通常需要升壓劑（在充分補液後）以維持灌流壓。"
  },

  {
    "id": "MED3_RENAL_INF_DER_ABX_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則｜降階" },
    "stem": "經驗性廣效抗生素治療後，培養結果回報單一敏感菌株且臨床穩定。最符合抗生素 stewardship 的下一步為何？",
    "options": [
      { "key": "A", "text": "維持原廣效抗生素直到療程結束" },
      { "key": "B", "text": "立即停用所有抗生素" },
      { "key": "C", "text": "依藥敏結果進行降階（de-escalation）到窄效治療" },
      { "key": "D", "text": "改用更廣效抗生素避免復發" }
    ],
    "answer": "C",
    "explanation": "降階可降低抗藥性壓力與藥物不良反應，且在培養與臨床資訊支持下通常不降低療效。"
  },
  {
    "id": "MED3_RENAL_INF_DER_ABX_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則｜腎功能" },
    "stem": "下列何者最正確描述「CKD 病人使用抗生素」的安全原則？",
    "options": [
      { "key": "A", "text": "只要不是 aminoglycoside 就不需調整劑量" },
      { "key": "B", "text": "多數需腎排除藥物應依 eGFR 調整劑量或給藥間隔" },
      { "key": "C", "text": "腎功能越差應使用越高劑量" },
      { "key": "D", "text": "腎功能不影響藥物蓄積" }
    ],
    "answer": "B",
    "explanation": "CKD 會降低多數腎排除抗生素清除率，需依 eGFR 調整劑量/間隔，以避免蓄積毒性與不必要的腎損傷。"
  },

  {
    "id": "MED3_RENAL_INF_DER_PNA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎｜CAP vs HAP" },
    "stem": "住院第 3 天出現新發咳嗽、發燒與肺浸潤影，最符合哪一種肺炎分類？",
    "options": [
      { "key": "A", "text": "社區型肺炎（CAP）" },
      { "key": "B", "text": "院內型肺炎（HAP）" },
      { "key": "C", "text": "吸入性肺炎（aspiration pneumonia）一定是" },
      { "key": "D", "text": "以上皆非" }
    ],
    "answer": "B",
    "explanation": "HAP 通常定義為住院 ≥48 小時後發生的肺炎。分類重點在時序與抗藥性風險，吸入性是病理機轉之一，不能單靠分類等同。"
  },
  {
    "id": "MED3_RENAL_INF_DER_PNA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎｜非典型菌" },
    "stem": "社區型肺炎若要涵蓋「非典型致病菌（atypical pathogens）」的經驗性治療考量，下列哪一類藥物最常用於涵蓋？",
    "options": [
      { "key": "A", "text": "β-lactam 單用即可" },
      { "key": "B", "text": "Macrolide 或 doxycycline（或呼吸道 fluoroquinolone）" },
      { "key": "C", "text": "抗黴菌藥" },
      { "key": "D", "text": "抗病毒藥單用" }
    ],
    "answer": "B",
    "explanation": "非典型菌（如 Mycoplasma、Chlamydophila、Legionella）缺乏典型細胞壁結構或表現不同，常需 macrolide/doxycycline 或呼吸道 FQ 來涵蓋；β-lactam 單用不一定涵蓋。"
  },

  {
    "id": "MED3_RENAL_INF_DER_UTI_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜上 vs 下" },
    "stem": "下列哪一項臨床表現最支持「腎盂腎炎（pyelonephritis）」而非單純膀胱炎？",
    "options": [
      { "key": "A", "text": "頻尿、急尿" },
      { "key": "B", "text": "排尿灼熱感" },
      { "key": "C", "text": "發燒合併肋脊角叩擊痛（CVA tenderness）" },
      { "key": "D", "text": "尿液混濁" }
    ],
    "answer": "C",
    "explanation": "腎盂腎炎屬上泌尿道感染，常見全身症狀（發燒、寒顫）與 CVA tenderness；膀胱炎多為下泌尿道症狀為主。"
  },
  {
    "id": "MED3_RENAL_INF_DER_UTI_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜複雜性" },
    "stem": "下列哪一項最符合「複雜性 UTI」的概念（通常需要更完整評估與療程）？",
    "options": [
      { "key": "A", "text": "健康非孕女性單純膀胱炎" },
      { "key": "B", "text": "男性 UTI 或合併尿路結構異常/導尿管" },
      { "key": "C", "text": "只有尿液培養陰性" },
      { "key": "D", "text": "症狀輕微即可視為單純" }
    ],
    "answer": "B",
    "explanation": "男性、孕婦、免疫低下、尿路阻塞/結構異常或導尿管相關感染常視為複雜性 UTI，抗藥性與併發症風險較高。"
  },

  {
    "id": "MED3_RENAL_INF_DER_SSTI_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚軟組織感染｜壞死性筋膜炎" },
    "stem": "懷疑壞死性筋膜炎時，下列哪一項處置最符合「救命關鍵」？",
    "options": [
      { "key": "A", "text": "先口服抗生素觀察 48 小時" },
      { "key": "B", "text": "等待影像學確診後才處理" },
      { "key": "C", "text": "緊急外科評估與手術清創，並合併廣效抗生素" },
      { "key": "D", "text": "只要退燒即可" }
    ],
    "answer": "C",
    "explanation": "壞死性筋膜炎進展快、致死率高，治療核心是及早手術清創＋廣效抗生素；影像可輔助但不能延誤手術時機。"
  },
  {
    "id": "MED3_RENAL_INF_DER_SSTI_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚軟組織感染｜蜂窩組織炎 vs 膿瘍" },
    "stem": "皮膚軟組織感染中，若臨床上懷疑「膿瘍（abscess）」形成，下列哪一項原則最正確？",
    "options": [
      { "key": "A", "text": "只要抗生素即可，不需處置" },
      { "key": "B", "text": "切開引流（I&D）常是治療核心，必要時再合併抗生素" },
      { "key": "C", "text": "一定要先做 MRI 才能治療" },
      { "key": "D", "text": "膿瘍與蜂窩組織炎處置完全相同" }
    ],
    "answer": "B",
    "explanation": "膿瘍的關鍵是排膿（I&D）；抗生素是輔助，依嚴重度、全身症狀或高風險族群決定是否加用。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列那一種藥物或狀況最不可能造成呼吸性鹼中毒？",
    "options": [
      { "key": "A", "text": "水楊酸鹽（salicylates）" },
      { "key": "B", "text": "高山" },
      { "key": "C", "text": "懷孕" },
      { "key": "D", "text": "嗎啡（morphine）" }
    ],
    "answer": "D",
    "explanation": "呼吸性鹼中毒多由過度換氣造成（如高山、懷孕、早期水楊酸鹽刺激呼吸中樞）。嗎啡會抑制呼吸、導致 CO2 retention，較可能造成呼吸性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "56 歲男性糖尿病人，Cr 2.0 mg/dL、K+ 5.8、Na+ 139、Cl− 116、HCO3− 18，尿滲透壓高，最可能的診斷為何？",
    "options": [
      { "key": "A", "text": "第二型腎小管酸血症（type 2 RTA）" },
      { "key": "B", "text": "Metformin 引發酸血症（metformin related acidosis）" },
      { "key": "C", "text": "低腎素低醛固酮血症（hyporeninemic hypoaldosteronism）" },
      { "key": "D", "text": "糖尿病酮酸血症（DKA）" }
    ],
    "answer": "C",
    "explanation": "糖尿病相關的低腎素低醛固酮血症屬於 type 4 RTA，典型為高血鉀合併非陰離子間隙代謝性酸中毒（HCO3− 下降）。DKA 通常為高陰離子間隙代謝酸且常伴酮體；type 2 RTA 常見低血鉀。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "35 歲女性因最近血壓升高就診，檢查多數正常但血清 K+ 2.5 mmol/L。下列哪一個診斷最不可能考慮？",
    "options": [
      { "key": "A", "text": "單側腎動脈狹窄（unilateral renal artery stenosis）" },
      { "key": "B", "text": "服用甘草（licorice）" },
      { "key": "C", "text": "Gordon 症候群（Gordon syndrome）" },
      { "key": "D", "text": "原發性皮質醛固酮症（primary aldosteronism）" }
    ],
    "answer": "C",
    "explanation": "低血鉀合併高血壓常見於高醛固酮或類醛固酮狀態（原發性醛固酮症、腎動脈狹窄造成 RAAS 活化、甘草造成 apparent mineralocorticoid excess）。Gordon syndrome（pseudohypoaldosteronism type 2）典型為高血壓合併高血鉀與高氯性代謝性酸中毒，與本題低血鉀不符。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "65 歲男性嘔吐兩天、血壓 85/50、ABG pH 7.49、PaCO2 47、HCO3− 32。下列對此病人的敘述何者最正確？",
    "options": [
      { "key": "A", "text": "血清滲透壓應該 > 310 mOsm/kg H2O" },
      { "key": "B", "text": "尿液鉀離子應該 < 10 mmol/L" },
      { "key": "C", "text": "尿液滲透壓應該 > 500 mOsm/kg H2O" },
      { "key": "D", "text": "尿液氯離子應該 > 20 mmol/L" }
    ],
    "answer": "C",
    "explanation": "嘔吐與容量不足常見代謝性鹼中毒，且因脫水尿液會濃縮（尿滲透壓上升）。容量不足時血清滲透壓不一定升高；代謝性鹼中毒常促進尿鉀流失（不一定低）；嘔吐造成的 chloride-depletion metabolic alkalosis 通常尿 Cl− 低（chloride responsive），不會 >20。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列哪一個病例較符合下列 ABG/電解質：pH 7.32、PaCO2 33、HCO3− 18、Na+ 138、Cl− 109？",
    "options": [
      { "key": "A", "text": "第一型糖尿病熬夜兩天忘記打胰島素" },
      { "key": "B", "text": "服用作用於遠端腎小管之利尿劑減重" },
      { "key": "C", "text": "第五期慢性腎臟病" },
      { "key": "D", "text": "腹瀉三天" }
    ],
    "answer": "D",
    "explanation": "此為代謝性酸中毒且陰離子間隙不高（non-anion gap metabolic acidosis），常見原因為 HCO3− 流失（如腹瀉）或 RTA。DKA/末期腎衰竭較偏高陰離子間隙代謝酸；多數利尿劑（loop/thiazide）傾向代謝性鹼中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "血陰離子隙（anion gap）主要反應下列何項離子的多寡？",
    "options": [
      { "key": "A", "text": "未測量之陽離子（unmeasured cations）" },
      { "key": "B", "text": "鈉離子＋鉀離子（Na+ + K+）" },
      { "key": "C", "text": "未測量之陰離子（unmeasured anions）" },
      { "key": "D", "text": "重碳酸離子＋氯離子（HCO3− + Cl−）" }
    ],
    "answer": "C",
    "explanation": "anion gap 概念上代表「未測量陰離子 − 未測量陽離子」。臨床上當乳酸、酮酸、毒物代謝物等未測量陰離子增加時，anion gap 上升。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列哪一個病例最不符合：pH 7.49、PaCO2 43、HCO3− 28、Na+ 139、K+ 3.0、Cl− 89？",
    "options": [
      { "key": "A", "text": "長期使用利尿劑" },
      { "key": "B", "text": "急性腹瀉三天" },
      { "key": "C", "text": "原發性皮質醛固酮症" },
      { "key": "D", "text": "噁心嘔吐兩天" }
    ],
    "answer": "B",
    "explanation": "此組數據為代謝性鹼中毒（HCO3− 上升）且呈低氯低鉀的型態。利尿劑、嘔吐、醛固酮過多皆可造成代謝性鹼中毒；腹瀉典型是 HCO3− 流失造成 non-anion gap 代謝性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "病人 ABG：pH 7.51、PaCO2 49 mmHg、HCO3− 38 mmol/L。下列何者正確？",
    "options": [
      { "key": "A", "text": "代謝性酸中毒" },
      { "key": "B", "text": "代謝性鹼中毒" },
      { "key": "C", "text": "呼吸性酸中毒" },
      { "key": "D", "text": "呼吸性鹼中毒" }
    ],
    "answer": "B",
    "explanation": "pH 偏鹼且 HCO3− 明顯上升，符合代謝性鹼中毒；PaCO2 上升可視為代償性通氣下降。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "承上題（pH 7.49、PaCO2 43、HCO3− 28、Na+ 139、K+ 3.0、Cl− 89），下列哪一個病例不符合該檢查結果？",
    "options": [
      { "key": "A", "text": "高血壓、間歇性下肢無力，醛固酮濃度升高（原發性醛固酮相關）" },
      { "key": "B", "text": "Sjogren syndrome，腎盂鈣化跡象（考慮 RTA）" },
      { "key": "C", "text": "急性胰臟炎住院，鼻胃管引流每日約 3000 mL" },
      { "key": "D", "text": "長期服用 thiazide diuretics 減肥" }
    ],
    "answer": "B",
    "explanation": "此題檢驗組合偏代謝性鹼中毒；A（醛固酮過多）、C（胃酸流失）、D（thiazide）均可造成代謝性鹼中毒。Sjogren syndrome 相關的遠端（type 1）RTA 則更典型為 non-anion gap 代謝性酸中毒，與題幹不符。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "承上題，若尿液氯離子濃度為 10 mmol/L，何者最符合此結果？",
    "options": [
      { "key": "A", "text": "甲病人（原發性醛固酮相關）" },
      { "key": "B", "text": "乙病人（Sjogren/RTA）" },
      { "key": "C", "text": "丙病人（鼻胃管引流大量胃液）" },
      { "key": "D", "text": "丁病人（持續使用 thiazide）" }
    ],
    "answer": "C",
    "explanation": "尿 Cl− < 20 mmol/L 支持 chloride-responsive metabolic alkalosis（如嘔吐/胃液流失、鼻胃管引流），補生理食鹽水可改善。原發性醛固酮與持續利尿劑使用多屬 chloride-resistant（尿 Cl− 常較高）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列何者不是高陰離子間隙代謝性酸中毒（high anion gap metabolic acidosis）的原因？",
    "options": [
      { "key": "A", "text": "Lactic acidosis" },
      { "key": "B", "text": "Ketoacidosis" },
      { "key": "C", "text": "Diarrhea（腹瀉）" },
      { "key": "D", "text": "Salicylate intoxication" }
    ],
    "answer": "C",
    "explanation": "高陰離子間隙代謝酸常見可用 Lactic、Keto、Toxins/Drugs、Renal failure 來記；腹瀉多為 HCO3− 流失造成 non-anion gap（高氯性）代謝酸。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列有關低腎素醛固酮分泌不足症（hyporeninemic hypoaldosteronism）的特徵敘述，何者正確？",
    "options": [
      { "key": "A", "text": "代謝性鹼中毒和高鉀血症" },
      { "key": "B", "text": "代謝性酸中毒和高鉀血症" },
      { "key": "C", "text": "代謝性鹼中毒和低鉀血症" },
      { "key": "D", "text": "代謝性酸中毒和低鈉血症" }
    ],
    "answer": "B",
    "explanation": "醛固酮作用為留鈉、排鉀、排酸；低腎素低醛固酮狀態會造成鉀與酸排不出去，典型呈現高血鉀合併代謝性酸中毒（type 4 RTA）。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "一位 40 歲女病人意識障礙，血中鈉離子 115 mmol/L，pH 7.40。下列關於該病人的敘述，何者錯誤？",
    "options": [
      { "key": "A", "text": "該病人的低血鈉症屬於嚴重（severe）" },
      { "key": "B", "text": "緊急處置必須包含靜脈滴注 3% sodium chloride（hypertonic saline）" },
      { "key": "C", "text": "用高濃度食鹽水靜脈輸注時應每 2 小時監測血清鈉濃度並調整輸注" },
      { "key": "D", "text": "補充血中鈉離子時，其上升速度不可超過 12–15 mmol/L/day" }
    ],
    "answer": "D",
    "explanation": "嚴重低血鈉合併神經症狀需以 3% 高張食鹽水緊急處置並密切監測。校正速度一般建議不超過約 10–12 mmol/L/day；若有高風險（如慢性低血鈉、營養不良、肝病、酒精使用等），常建議更保守（例如 ≤8 mmol/L/day），以避免滲透性脫髓鞘症候群。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "75 歲女性主訴最近 1 個月食慾不振與全身虛弱。過去病史：高血壓、糖尿病。身體檢查：意識清楚，血壓 110/70 mmHg，心跳 76/min，無水腫，黏膜乾。Na 117 mmol/L，K 3.5 mmol/L，BUN 30 mg/dL，Cr 1.0 mg/dL。下列敘述何者最不適當？",
    "options": [
      { "key": "A", "text": "病人可能為低容積型低血鈉（hypovolemic hyponatremia）" },
      { "key": "B", "text": "病人應該限制水分攝取" },
      { "key": "C", "text": "緊急處置必須包含靜脈滴注 3% hypertonic saline" },
      { "key": "D", "text": "治療應包含靜脈滴注 0.9% sodium chloride（normal saline）" }
    ],
    "answer": "C",
    "explanation": "此例更像慢性、相對穩定且偏低容積型低血鈉，通常優先矯正體液狀態（如 0.9% NS、停用誘因如利尿劑、評估腎上腺/甲狀腺等），未必需要 3% 高張食鹽水。高張食鹽水主要用於合併中度/重度神經症狀的低血鈉。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列關於低血鈉的鑑別診斷，何者最不適當？",
    "options": [
      { "key": "A", "text": "甲狀腺功能低下可能會造成低血鈉" },
      { "key": "B", "text": "利尿劑所造成的腎臟鹽分流失可能造成尿液中鈉濃度高於 20 mM" },
      { "key": "C", "text": "燒傷或腹瀉可能造成尿液中鈉濃度低於 20 mM" },
      { "key": "D", "text": "心衰竭造成的高容積型低血鈉，其尿液中鈉濃度通常大於 20 mM" }
    ],
    "answer": "D",
    "explanation": "心衰竭的高容積型低血鈉通常「有效循環血量下降」→ RAAS 活化 → 腎臟保鈉，因此尿鈉多偏低（常 <20 mM）。尿鈉偏高較符合腎性鹽分流失或 SIADH 等情境。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "Vaptans 可以用於治療哪一種低血鈉症？",
    "options": [
      { "key": "A", "text": "SIADH" },
      { "key": "B", "text": "脫水所造成的低血鈉" },
      { "key": "C", "text": "無症狀的低血鈉" },
      { "key": "D", "text": "伴隨神經症狀的 SIADH" }
    ],
    "answer": "A",
    "explanation": "Vaptans（vasopressin receptor antagonists）主要用於水分排除不當的低血鈉（如 SIADH；亦可見於部分高容積型低血鈉）。伴嚴重神經症狀者多以高張食鹽水急救為先。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_DI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉/尿崩鑑別" },
    "stem": "一位 20 歲男性有嚴重多尿。禁水 4 小時後小便滲透壓沒有明顯上升；注射 desmopressin 後小便滲透壓亦沒有明顯上升。最可能的診斷為何？",
    "options": [
      { "key": "A", "text": "中樞型尿崩症（central diabetes insipidus）" },
      { "key": "B", "text": "腎性尿崩症（nephrogenic diabetes insipidus）" },
      { "key": "C", "text": "不適當抗利尿激素症候群（SIADH）" },
      { "key": "D", "text": "心因性多飲（psychogenic polydipsia）" }
    ],
    "answer": "B",
    "explanation": "禁水後尿滲透壓未上升代表無法濃縮尿；給予 desmopressin 仍無反應更支持腎臟對 ADH 不敏感（腎性尿崩症），而非中樞型尿崩症。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "56 歲男性腎病症候群，血液 osmolality 255 mOsm/kg、Na 120 mmol/L。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "病人的細胞外液（ECF）容積增加" },
      { "key": "B", "text": "病人的細胞內液（ICF）容積增加" },
      { "key": "C", "text": "病人的有效循環血量（effective blood volume）增加" },
      { "key": "D", "text": "病人的有效循環血量（effective blood volume）下降" }
    ],
    "answer": "C",
    "explanation": "腎病症候群可見水腫（ECF 增加），且低滲狀態水分可進入細胞（ICF 增加）；但因膠體滲透壓下降與有效循環血量下降而促進保水保鈉，因此 effective blood volume 下降較符合。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列有關低血鈉症的描述，何者正確？",
    "options": [
      { "key": "A", "text": "如果血漿滲透壓低，應該考慮是否為高血糖造成的假性低血鈉" },
      { "key": "B", "text": "心衰竭可能造成細胞外液增加與低血鈉症" },
      { "key": "C", "text": "低容積型低血鈉合併尿鈉 <10 mmol/L 表示腎病變造成鈉流失" },
      { "key": "D", "text": "SIADH 的血漿滲透壓通常正常且 ECF 減少" }
    ],
    "answer": "B",
    "explanation": "心衰竭可造成高容積型低血鈉。高血糖造成的低血鈉多是「高滲」情境；低容積且尿鈉很低常見於腎外流失（如腹瀉、嘔吐）；SIADH 通常為低滲、近似正容積（euvolemic）低血鈉。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列那一種低血鈉症最適合使用 0.9% sodium chloride（normal saline）治療？",
    "options": [
      { "key": "A", "text": "SIADH" },
      { "key": "B", "text": "心衰竭" },
      { "key": "C", "text": "aldosterone deficiency" },
      { "key": "D", "text": "肝硬化" }
    ],
    "answer": "C",
    "explanation": "等張食鹽水最適合用於低容積型低血鈉（例如腎上腺/醛固酮不足、腎外液體流失等）以回復有效循環血量；SIADH/心衰竭/肝硬化多屬非低容積型，治療策略不同。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "88 歲男性因近乎昏厥送急診。Lab：Na 124 mmol/L、K 3.5 mmol/L、Cl 94 mmol/L、BUN 15.3 mg/dL、Cr 0.92 mg/dL、troponin I <0.012 ng/mL、hsTSH 66.7 μIU/mL。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "該病人是低血鈉症" },
      { "key": "B", "text": "應評估是否有內分泌原因（如甲狀腺或腎上腺）" },
      { "key": "C", "text": "此案例需將甲狀腺功能異常納入鑑別診斷" },
      { "key": "D", "text": "抽血結果較符合 hyperthyroidism（甲狀腺機能亢進）" }
    ],
    "answer": "D",
    "explanation": "hsTSH 顯著上升更支持甲狀腺機能低下（hypothyroidism），而非甲狀腺機能亢進。甲狀腺機能低下可造成低血鈉，需納入鑑別。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "關於 SIADH（syndrome of inappropriate ADH secretion），下列何者可能是造成低血鈉症的原因？",
    "options": [
      { "key": "A", "text": "Cefazolin (Kefzol)" },
      { "key": "B", "text": "肺部感染" },
      { "key": "C", "text": "E. coli 感染" },
      { "key": "D", "text": "Group B streptococcus 感染" }
    ],
    "answer": "B",
    "explanation": "SIADH 常與肺部病灶/肺炎、CNS 病變、部分腫瘤（如小細胞肺癌）或特定藥物相關；肺部感染是經典誘因之一。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "63 歲男性肺癌病人接受化學治療三天後因意識不清送急診。Vitals：BP 124/75、HR 78、RR 18。Lab：Na 108 mmol/L、K 4.0 mmol/L、Cl 80 mmol/L、HCO3 22 mmol/L、BUN 15 mg/dL、Cr 0.9 mg/dL、serum osmolality 232 mOsm/kg、urine osmolality 450 mOsm/kg、urine Na 45 mmol/L。下列敘述何者正確？",
    "options": [
      { "key": "A", "text": "病人可能為 euvolemic hyponatremia" },
      { "key": "B", "text": "病人可能為 hypovolemic hyponatremia" },
      { "key": "C", "text": "病人可能為 hypervolemic hyponatremia" },
      { "key": "D", "text": "病人可能為 pseudohyponatremia" }
    ],
    "answer": "A",
    "explanation": "低血鈉且低血漿滲透壓，合併尿滲透壓偏高與尿鈉偏高，符合 ADH 不當上升/腎臟未適當排水的型態，最典型為 SIADH；臨床上多呈 euvolemic hyponatremia。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "一名 60 歲婦女因意識不清與倦怠住院。病人有糖尿病，長期服用 metformin。檢查發現血鈉 110 mmol/L、血漿滲透壓 225 mOsm/kg、尿滲透壓 400 mOsm/kg。影像顯示肺部小細胞癌。若太快校正此病人的電解質異常，最擔心發生下列何種併發症？",
    "options": [
      { "key": "A", "text": "反彈性高血糖（rebound hyperglycemia）" },
      { "key": "B", "text": "滲透性大腦去髓鞘症候群（osmotic cerebral demyelination syndrome）" },
      { "key": "C", "text": "反彈性低血鈉（rebound hyponatremia）" },
      { "key": "D", "text": "急性腎衰竭（acute renal failure）" }
    ],
    "answer": "B",
    "explanation": "慢性或長期低血鈉若矯正過快，最重要的致命/致殘風險為滲透性脫髓鞘（中央橋腦溶解等）。因此校正速率需嚴格控制並密切監測。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERNa_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜B 高血鈉" },
    "stem": "35 歲女性病人意識不清，血中 Na 160 mmol/L。下列處置何者最適當？",
    "options": [
      { "key": "A", "text": "計算 free water deficit 並用 5% dextrose（D5W）緩慢矯正" },
      { "key": "B", "text": "使用 3% hypertonic saline 緊急矯正" },
      { "key": "C", "text": "以 0.9% normal saline 迅速矯正至正常" },
      { "key": "D", "text": "不需處置，觀察即可" }
    ],
    "answer": "A",
    "explanation": "高血鈉代表缺水或自由水相對不足；處置重點是估算自由水缺乏量並以低滲液（如 D5W 或口服/腸道補水）緩慢矯正，避免矯正過快造成腦水腫。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_PHYSIO_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜腎臟生理" },
    "stem": "注射 ADH 後，腎臟哪一處對水的通透度增加最顯著？",
    "options": [
      { "key": "A", "text": "Proximal convoluted tubule" },
      { "key": "B", "text": "Ascending limb of the loop of Henle" },
      { "key": "C", "text": "Distal tubule" },
      { "key": "D", "text": "Collecting duct" }
    ],
    "answer": "D",
    "explanation": "ADH 主要增加集合管（尤其皮質/髓質集合管）主細胞的水通道（AQP2）插入，顯著提升水通透度；晚期遠曲小管亦可受影響，但臨床與考題多以 collecting duct 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERK_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜D 高血鉀" },
    "stem": "下列何者最不會導致高血鉀（hyperkalemia）的發生？",
    "options": [
      { "key": "A", "text": "Excessive intake of potassium" },
      { "key": "B", "text": "Potassium-sparing diuretics" },
      { "key": "C", "text": "Angiotensin-converting enzyme inhibitors" },
      { "key": "D", "text": "NSAIDs (nonsteroidal anti-inflammatory drugs)" }
    ],
    "answer": "A",
    "explanation": "單純高鉀攝取在腎功能正常者通常可由腎臟排除，不一定造成高血鉀；相對地，保鉀利尿劑、ACEi、NSAIDs（抑制腎素/醛固酮軸）均可降低排鉀能力而導致高血鉀。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERK_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜腎小管細胞" },
    "stem": "Cortical collecting duct cells 中，哪一種細胞負責 reabsorb sodium？",
    "options": [
      { "key": "A", "text": "Principal cells" },
      { "key": "B", "text": "Type A intercalated cells" },
      { "key": "C", "text": "Type B intercalated cells" },
      { "key": "D", "text": "Macula densa cells" }
    ],
    "answer": "A",
    "explanation": "集合管 principal cells 主要負責鈉再吸收（ENaC）與鉀分泌；Type A/B intercalated cells 主要與酸鹼調節相關。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "關於低血鉀症（hypokalemia），下列敘述何者最不適當？",
    "options": [
      { "key": "A", "text": "會造成 muscle weakness" },
      { "key": "B", "text": "會使 PR interval prolonged" },
      { "key": "C", "text": "會增加 T wave amplitude" },
      { "key": "D", "text": "會導致 cardiac arrhythmia" }
    ],
    "answer": "C",
    "explanation": "低血鉀常見心電圖變化包含 T wave 變平、U wave、ST depression、QT 延長與心律不整風險上升；不會造成 T wave amplitude 增加。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "80 歲女性低血鉀（K 2.5 mmol/L），血液 pH 7.50、HCO3 35 mEq/L。下列處置何者最不適當？",
    "options": [
      { "key": "A", "text": "給予 potassium chloride 補充" },
      { "key": "B", "text": "停用可能導致低血鉀的利尿劑並評估病因" },
      { "key": "C", "text": "以 5% dextrose（葡萄糖水）作為補鉀輸液的溶媒" },
      { "key": "D", "text": "測定血清鎂離子並於需要時補充鎂" }
    ],
    "answer": "C",
    "explanation": "葡萄糖輸注會促進胰島素分泌，使鉀離子移入細胞，可能惡化低血鉀；補鉀通常避免使用含葡萄糖溶液作為主要溶媒（除非有特殊情境並嚴密監測）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "25 歲男性下肢無力至急診。K 2.0 mmol/L、pH 7.40、HCO3 24 mmol/L、磷 1.8 mg/dL、尿鉀 10 mmol/L、尿滲透壓 580 mOsm/kg、無服用利尿劑。下列何者最適當？",
    "options": [
      { "key": "A", "text": "立刻停止葡萄糖輸液避免低血鉀惡化" },
      { "key": "B", "text": "以周邊靜脈快速給予 KCl 10–20 mEq/hr 並不需進一步評估" },
      { "key": "C", "text": "加驗甲狀腺功能以評估甲狀腺毒性週期性麻痺（thyrotoxic periodic paralysis）" },
      { "key": "D", "text": "計算 TTKG 以確診腎性鉀流失為主因" }
    ],
    "answer": "C",
    "explanation": "年輕男性、急性麻痺、低血鉀合併低血磷且尿鉀不高，較像鉀移入細胞（shift）型低血鉀；典型鑑別為甲狀腺毒性週期性麻痺，應加驗甲狀腺功能並同時謹慎補鉀、治療誘因。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "依 KDIGO 定義，下列何者符合急性腎損傷（AKI）診斷？",
    "options": [
      { "key": "A", "text": "血清 creatinine 於 48 小時內上升 ≥0.3 mg/dL" },
      { "key": "B", "text": "eGFR 下降但持續不到 1 週" },
      { "key": "C", "text": "血清 creatinine 於 1 個月內上升 10%" },
      { "key": "D", "text": "任何一次 creatinine 高於正常上限" }
    ],
    "answer": "A",
    "explanation": "KDIGO AKI 其中一個診斷標準為 48 小時內 SCr 上升 ≥0.3 mg/dL（或 7 天內 ≥1.5 倍基準值，或尿量 <0.5 mL/kg/hr 持續 ≥6 小時）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "腎前性 AKI 最典型的尿液檢查特徵為何？",
    "options": [
      { "key": "A", "text": "尿液鈉濃度高、FENa >2%" },
      { "key": "B", "text": "尿滲透壓偏高、尿鈉偏低" },
      { "key": "C", "text": "尿沈渣大量 RBC casts" },
      { "key": "D", "text": "尿沈渣大量 WBC casts" }
    ],
    "answer": "B",
    "explanation": "腎前性 AKI 因腎小管功能尚可，會強烈保鈉保水：尿鈉低、尿滲透壓高、FENa 多 <1%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "懷疑腎後性（postrenal）AKI 時，最實用的第一線影像檢查為何？",
    "options": [
      { "key": "A", "text": "腎臟超音波（評估 hydronephrosis）" },
      { "key": "B", "text": "腎臟 MRI" },
      { "key": "C", "text": "腎臟穿刺切片" },
      { "key": "D", "text": "腎臟核醫掃描" }
    ],
    "answer": "A",
    "explanation": "腎後性 AKI 先找阻塞：腎臟超音波可快速評估是否有腎盂腎盞擴張（hydronephrosis），臨床最常用也最安全。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "下列何者最符合急性間質性腎炎（acute interstitial nephritis, AIN）的典型線索？",
    "options": [
      { "key": "A", "text": "泥沙樣圓柱（muddy brown casts）" },
      { "key": "B", "text": "發燒、皮疹、嗜酸性球上升（可出現）" },
      { "key": "C", "text": "大量蛋白尿 >3.5 g/day" },
      { "key": "D", "text": "嚴重低補體血症為最典型" }
    ],
    "answer": "B",
    "explanation": "AIN 常與藥物/感染相關，典型提示可見發燒、皮疹、嗜酸性球上升（不一定三者俱全），尿液可見白血球、白血球圓柱；A 更像 ATN。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "疑似橫紋肌溶解（rhabdomyolysis）導致 AKI 時，尿液 dipstick 與尿沈渣的典型組合為何？",
    "options": [
      { "key": "A", "text": "dipstick 血尿陰性，尿沈渣大量 RBC" },
      { "key": "B", "text": "dipstick 血尿陽性，但尿沈渣 RBC 很少或沒有" },
      { "key": "C", "text": "dipstick 白血球酯酶陽性，尿沈渣 WBC casts" },
      { "key": "D", "text": "dipstick 蛋白陽性且必定 >3.5 g/day" }
    ],
    "answer": "B",
    "explanation": "myoglobin 會讓 dipstick 呈「heme 陽性」，但顯微鏡下 RBC 不多（或無），合併 CK 大幅升高可支持 rhabdomyolysis。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "預防造影劑相關腎損傷（contrast-associated AKI）最有效且最常用的策略為何？",
    "options": [
      { "key": "A", "text": "常規使用利尿劑促進排尿" },
      { "key": "B", "text": "常規使用 NSAIDs 減少發炎" },
      { "key": "C", "text": "等張液體補充（如 0.9% NS）作為周邊水化" },
      { "key": "D", "text": "給予高張食鹽水快速矯正腎灌流" }
    ],
    "answer": "C",
    "explanation": "高風險病人接受含碘造影前後，最核心的可行策略是等張水化（IV isotonic fluids），並同時避免腎毒性藥物與控制造影劑劑量。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "AKI 需緊急透析的適應症（AEIOU）中，下列何者最符合 “E” 的意義？",
    "options": [
      { "key": "A", "text": "Encephalopathy（尿毒性腦病變）" },
      { "key": "B", "text": "Edema（難以控制的肺水腫/容量負荷）" },
      { "key": "C", "text": "Elevated creatinine（肌酸酐升高）" },
      { "key": "D", "text": "Eosinophilia（嗜酸性球上升）" }
    ],
    "answer": "B",
    "explanation": "AEIOU：Acidosis（難以控制酸中毒）、Electrolytes（高鉀等）、Intoxications、Overload（容量負荷/肺水腫）、Uremia（尿毒症狀）。其中 “O” 也常寫 Overload；此題以 Edema/Overload 對應。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "下列何者最支持腎小球來源的血尿（glomerular hematuria）？",
    "options": [
      { "key": "A", "text": "尿沈渣見 dysmorphic RBC 或 RBC casts" },
      { "key": "B", "text": "尿液中 nitrite 陽性" },
      { "key": "C", "text": "尿液中大量結晶" },
      { "key": "D", "text": "尿比重偏低（低滲尿）" }
    ],
    "answer": "A",
    "explanation": "腎小球出血常見變形紅血球（dysmorphic RBC）與 RBC casts；nitrite 更支持細菌性 UTI。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "成人腎病症候群最常見的原發性腎小球疾病為何？",
    "options": [
      { "key": "A", "text": "Minimal change disease" },
      { "key": "B", "text": "Membranous nephropathy" },
      { "key": "C", "text": "Post-streptococcal GN" },
      { "key": "D", "text": "Alport syndrome" }
    ],
    "answer": "B",
    "explanation": "兒童腎病症候群最常見為 minimal change disease；成人則常以 membranous nephropathy 與 FSGS 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "Minimal change disease 最典型的病理/臨床線索為何？",
    "options": [
      { "key": "A", "text": "光顯可見節段性硬化，IF 顯示 IgA 沉積" },
      { "key": "B", "text": "電顯可見足突融合（foot process effacement），對類固醇反應佳" },
      { "key": "C", "text": "光顯可見明顯增生伴新月體形成" },
      { "key": "D", "text": "與 HBV/HCV 最相關，常合併低補體" }
    ],
    "answer": "B",
    "explanation": "Minimal change disease 的核心是 podocyte injury，電顯足突融合最典型，臨床上對類固醇治療反應佳。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "Membranous nephropathy 最典型的免疫螢光（IF）型態為何？",
    "options": [
      { "key": "A", "text": "線狀（linear）沉積沿 GBM" },
      { "key": "B", "text": "顆粒狀（granular）沉積沿 GBM" },
      { "key": "C", "text": "僅在系膜（mesangium）IgA 沉積" },
      { "key": "D", "text": "完全無免疫沉積（pauci-immune）" }
    ],
    "answer": "B",
    "explanation": "Membranous nephropathy 為免疫複合體沉積型腎小球病變，典型 IF 為沿 GBM 顆粒狀 IgG/C3 沉積。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "下列何者最符合 diabetic nephropathy 的臨床自然史？",
    "options": [
      { "key": "A", "text": "突然肉眼血尿、補體下降、腎功能急速惡化" },
      { "key": "B", "text": "先出現 microalbuminuria，之後進展至蛋白尿與 eGFR 下降" },
      { "key": "C", "text": "典型為反覆上呼吸道感染後 1–2 天血尿" },
      { "key": "D", "text": "多為 isolated hematuria，蛋白尿很少見" }
    ],
    "answer": "B",
    "explanation": "糖尿病腎病變常先由微量白蛋白尿開始，之後進展到顯性蛋白尿並逐步腎功能下降。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎炎症候群" },
    "stem": "急性鏈球菌感染後腎炎（PSGN）最典型的補體變化為何？",
    "options": [
      { "key": "A", "text": "C3 下降且 C4 下降" },
      { "key": "B", "text": "C3 下降、C4 通常正常" },
      { "key": "C", "text": "C3 正常、C4 下降" },
      { "key": "D", "text": "C3 與 C4 都正常" }
    ],
    "answer": "B",
    "explanation": "PSGN 常見替代路徑活化，典型表現為低 C3、C4 多正常，並會在數週內逐漸恢復。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎炎症候群" },
    "stem": "IgA 腎病變與 PSGN 的鑑別重點之一是血尿出現的時序。下列何者正確？",
    "options": [
      { "key": "A", "text": "IgA 腎病變多在感染後 1–2 天內出現血尿" },
      { "key": "B", "text": "IgA 腎病變多在感染後 2–3 週出現血尿" },
      { "key": "C", "text": "PSGN 多在感染後 1–2 天內出現血尿" },
      { "key": "D", "text": "兩者皆與感染無關" }
    ],
    "answer": "A",
    "explanation": "IgA 腎病變常見「synpharyngitic hematuria」：上呼吸道感染後很短時間（1–2 天）血尿；PSGN 則多在 1–3 週後。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "RPGN 的病理最具代表性的描述為何？",
    "options": [
      { "key": "A", "text": "腎小管上皮壞死為主" },
      { "key": "B", "text": "腎小球新月體（crescents）形成" },
      { "key": "C", "text": "腎小球基底膜均勻變厚且無增生" },
      { "key": "D", "text": "腎間質大量脂肪沉積" }
    ],
    "answer": "B",
    "explanation": "RPGN 的經典病理為腎小球新月體形成，代表嚴重腎小球發炎/破壞，臨床多呈快速腎功能惡化。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "Goodpasture syndrome（anti-GBM disease）最典型的 IF 表現為何？",
    "options": [
      { "key": "A", "text": "顆粒狀（granular）IgG 沿 GBM" },
      { "key": "B", "text": "線狀（linear）IgG 沿 GBM" },
      { "key": "C", "text": "僅系膜 IgA 沉積" },
      { "key": "D", "text": "無免疫沉積（pauci-immune）" }
    ],
    "answer": "B",
    "explanation": "anti-GBM disease 的特色為抗體直接針對 GBM，IF 典型呈線狀（linear）IgG 沉積。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "ANCA-associated vasculitis 造成的腎炎在腎切片免疫螢光上最典型的特徵為何？",
    "options": [
      { "key": "A", "text": "線狀 IgG 沉積" },
      { "key": "B", "text": "顆粒狀 IgG/C3 沉積" },
      { "key": "C", "text": "pauci-immune（免疫沉積很少或幾乎沒有）" },
      { "key": "D", "text": "只出現 IgA 沉積" }
    ],
    "answer": "C",
    "explanation": "ANCA 相關血管炎的腎炎通常為 pauci-immune crescentic GN：免疫沉積少，但發炎破壞嚴重、可見新月體。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜次發性腎小球疾病" },
    "stem": "下列哪一種情境最符合 membranous nephropathy 的重要次發性原因之一？",
    "options": [
      { "key": "A", "text": "Hepatitis B / malignancy（如實體腫瘤）" },
      { "key": "B", "text": "急性腸胃炎造成脫水" },
      { "key": "C", "text": "腎結石造成血尿" },
      { "key": "D", "text": "心因性多飲" }
    ],
    "answer": "A",
    "explanation": "Membranous nephropathy 可為原發或次發；次發性常與惡性腫瘤、HBV、部分自體免疫疾病或藥物相關。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜次發性腎小球疾病" },
    "stem": "Lupus nephritis 常見的免疫學線索中，下列何者最典型？",
    "options": [
      { "key": "A", "text": "anti-GBM 抗體陽性、IF 呈線狀 IgG" },
      { "key": "B", "text": "ANA/anti-dsDNA 相關，且常見低補體" },
      { "key": "C", "text": "只會造成 isolated hematuria，蛋白尿罕見" },
      { "key": "D", "text": "尿鈉 <10 mmol/L 為診斷關鍵" }
    ],
    "answer": "B",
    "explanation": "狼瘡腎炎常與 ANA、anti-dsDNA 上升及補體消耗（C3/C4 下降）相關，臨床可表現蛋白尿、血尿與腎功能異常。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群併發症" },
    "stem": "腎病症候群常見併發症，下列何者最正確？",
    "options": [
      { "key": "A", "text": "出血傾向增加，最擔心顱內出血" },
      { "key": "B", "text": "血栓風險增加，特別是腎靜脈栓塞" },
      { "key": "C", "text": "白血球大量上升是典型" },
      { "key": "D", "text": "必定出現高鈣血症" }
    ],
    "answer": "B",
    "explanation": "腎病症候群因抗凝因子（如 antithrombin III）流失與高凝狀態，血栓風險上升；腎靜脈栓塞是典型考點之一。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "下列何者不是急性透析的典型適應症（AEIOU）？",
    "options": [
      { "key": "A", "text": "難以控制的代謝性酸中毒" },
      { "key": "B", "text": "高血鉀合併心電圖變化" },
      { "key": "C", "text": "血肌酸酐上升但無症狀" },
      { "key": "D", "text": "容量負荷導致肺水腫且對利尿劑反應差" }
    ],
    "answer": "C",
    "explanation": "透析是因「併發症/症狀」與無法控制的代謝/容量問題，而非單看 creatinine 數值。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "下列何者最適合做為長期血液透析（HD）的血管通路？",
    "options": [
      { "key": "A", "text": "周邊靜脈留置針" },
      { "key": "B", "text": "動靜脈瘻管（AV fistula）" },
      { "key": "C", "text": "短期未隧道化中心靜脈導管" },
      { "key": "D", "text": "腹膜透析導管" }
    ],
    "answer": "B",
    "explanation": "長期 HD 首選 AV fistula（感染與血栓風險較低、壽命較長）；中心靜脈導管多作為短期或橋接。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "透析失衡症候群（dialysis disequilibrium syndrome）最典型的情境為何？",
    "options": [
      { "key": "A", "text": "長期規則透析病人，每次透析後" },
      { "key": "B", "text": "初次或久未透析、BUN 很高者接受快速透析後" },
      { "key": "C", "text": "腹膜透析病人使用高糖透析液後" },
      { "key": "D", "text": "腎移植後使用 tacrolimus 期間" }
    ],
    "answer": "B",
    "explanation": "高尿素血症病人若快速清除溶質，易造成腦內外滲透壓差→腦水腫，出現頭痛、噁心、抽搐、意識改變。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "腹膜透析（PD）最常見且最重要的急性併發症為何？",
    "options": [
      { "key": "A", "text": "腦出血" },
      { "key": "B", "text": "腹膜炎（peritonitis）" },
      { "key": "C", "text": "致命性心律不整" },
      { "key": "D", "text": "高血糖一定發生" }
    ],
    "answer": "B",
    "explanation": "PD 主要急症為腹膜炎，典型為腹痛、混濁透析液、發燒，需立即評估與抗生素治療。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "關於腹膜透析（PD）的溶質清除原理，下列何者最正確？",
    "options": [
      { "key": "A", "text": "主要靠對流（convection）" },
      { "key": "B", "text": "主要靠擴散（diffusion），超濾靠滲透壓梯度" },
      { "key": "C", "text": "主要靠腎小球濾過" },
      { "key": "D", "text": "主要靠腎小管分泌" }
    ],
    "answer": "B",
    "explanation": "PD 的小分子清除以擴散為主；液體移除（ultrafiltration）則靠透析液葡萄糖等造成的滲透壓梯度。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後「超急性排斥（hyperacute rejection）」最常見的機轉為何？",
    "options": [
      { "key": "A", "text": "T cell-mediated delayed hypersensitivity" },
      { "key": "B", "text": "既存抗體（preformed antibodies）造成補體活化與血栓" },
      { "key": "C", "text": "藥物毒性造成腎小管壞死" },
      { "key": "D", "text": "病毒感染造成腎炎" }
    ],
    "answer": "B",
    "explanation": "超急性排斥多因既存 anti-HLA/ABO 抗體，移植後立即引發補體活化、血管內血栓、移植腎快速失敗。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後早期（數天到數週）出現 creatinine 上升，超音波無阻塞、血流尚可。下列何者最需要優先考慮？",
    "options": [
      { "key": "A", "text": "急性排斥反應或 CNI（如 tacrolimus）毒性" },
      { "key": "B", "text": "腎細胞癌轉移" },
      { "key": "C", "text": "多囊腎破裂" },
      { "key": "D", "text": "腎結石一定是主因" }
    ],
    "answer": "A",
    "explanation": "移植後早期腎功能惡化的常見鑑別包含急性排斥、CNI 藥物毒性、感染、脫水、血管/尿路併發症等；已排除阻塞與主要血流問題時，排斥/藥毒性要優先想。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "下列何者最典型屬於 calcineurin inhibitor（CNI，例如 cyclosporine/tacrolimus）的副作用？",
    "options": [
      { "key": "A", "text": "腎毒性與高血壓" },
      { "key": "B", "text": "嚴重骨髓抑制為主" },
      { "key": "C", "text": "不可逆的聽力喪失" },
      { "key": "D", "text": "腎結石一定形成" }
    ],
    "answer": "A",
    "explanation": "CNI 常見腎血管收縮導致腎毒性、亦可造成高血壓、神經毒性、電解質異常等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後長期免疫抑制最常見的感染風險之一為何？",
    "options": [
      { "key": "A", "text": "CMV 相關感染" },
      { "key": "B", "text": "霍亂" },
      { "key": "C", "text": "破傷風" },
      { "key": "D", "text": "狂犬病" }
    ],
    "answer": "A",
    "explanation": "移植後免疫抑制常增加機會性感染風險，CMV 是常考也常見的重要病原。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "最常見的腎結石成分為何？",
    "options": [
      { "key": "A", "text": "Calcium oxalate" },
      { "key": "B", "text": "Cystine" },
      { "key": "C", "text": "Uric acid" },
      { "key": "D", "text": "Struvite（magnesium ammonium phosphate）" }
    ],
    "answer": "A",
    "explanation": "最常見為鈣結石，以 calcium oxalate 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最典型與 struvite stone 相關？",
    "options": [
      { "key": "A", "text": "高草酸飲食" },
      { "key": "B", "text": "urease-producing bacteria 感染" },
      { "key": "C", "text": "低尿酸血症" },
      { "key": "D", "text": "長期低鈣飲食" }
    ],
    "answer": "B",
    "explanation": "struvite stone 與 urease-producing bacteria（如 Proteus、部分 Klebsiella 等）相關，尿液偏鹼性，常形成鹿角狀結石（staghorn calculus）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最符合 uric acid stone 的特性？",
    "options": [
      { "key": "A", "text": "尿液偏鹼性、結石多為放射線不透（radiopaque）" },
      { "key": "B", "text": "尿液偏酸性、結石多為放射線透亮（radiolucent）" },
      { "key": "C", "text": "與 urease bacteria 感染最相關" },
      { "key": "D", "text": "一定合併高血鈣" }
    ],
    "answer": "B",
    "explanation": "uric acid stone 常在酸性尿形成，且多為 radiolucent（X 光不易看到，CT 可見）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "腎絞痛合併發燒、疑似阻塞併感染時，下列何者為最重要的處置原則？",
    "options": [
      { "key": "A", "text": "止痛後門診追蹤即可" },
      { "key": "B", "text": "先等結石自然排出再給抗生素" },
      { "key": "C", "text": "緊急引流解除阻塞（stent/PCN）並合併抗生素" },
      { "key": "D", "text": "僅給利尿劑促進排石" }
    ],
    "answer": "C",
    "explanation": "阻塞合併感染是泌尿道敗血症風險情境，關鍵是「引流解除阻塞＋抗生素」，不能只靠止痛或等待排石。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最符合 cystine stone 的線索？",
    "options": [
      { "key": "A", "text": "尿液中六角形（hexagonal）結晶" },
      { "key": "B", "text": "尿液偏鹼性且與 urease bacteria 相關" },
      { "key": "C", "text": "與高尿酸血症最相關" },
      { "key": "D", "text": "多見於老年人且與吸菸相關" }
    ],
    "answer": "A",
    "explanation": "cystinuria 的典型尿沉渣為六角形結晶；屬遺傳性胺基酸運輸異常。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "成人常見的遺傳性多囊腎（ADPKD）最典型的腎外併發症為何？",
    "options": [
      { "key": "A", "text": "甲狀腺癌" },
      { "key": "B", "text": "顱內動脈瘤（berry aneurysm）" },
      { "key": "C", "text": "原發性肺纖維化" },
      { "key": "D", "text": "硬皮症" }
    ],
    "answer": "B",
    "explanation": "ADPKD 重要腎外併發症包含顱內動脈瘤、肝囊腫、二尖瓣脫垂等；其中 berry aneurysm 是高風險考點。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "ADPKD 病人出現肉眼血尿與側腹痛時，下列何者最需要納入鑑別？",
    "options": [
      { "key": "A", "text": "囊腫出血或感染" },
      { "key": "B", "text": "必定是 PSGN" },
      { "key": "C", "text": "必定是腎移植排斥" },
      { "key": "D", "text": "一定是藥物性 AIN" }
    ],
    "answer": "A",
    "explanation": "ADPKD 常見症狀包含側腹痛、肉眼血尿；常見原因為囊腫出血、囊腫感染或結石等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "ADPKD 最常用於篩檢/初步診斷的影像工具為何？",
    "options": [
      { "key": "A", "text": "腎臟超音波" },
      { "key": "B", "text": "腎臟 PET-CT" },
      { "key": "C", "text": "腎臟穿刺切片" },
      { "key": "D", "text": "腎動脈攝影" }
    ],
    "answer": "A",
    "explanation": "腎臟超音波是最常用、方便且無侵入性的初步診斷工具；必要時可用 CT/MRI 進一步評估。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "腎細胞癌（RCC）典型三徵（classic triad）為何？",
    "options": [
      { "key": "A", "text": "咳嗽、咳血、胸痛" },
      { "key": "B", "text": "血尿、側腹痛、可觸及腫塊" },
      { "key": "C", "text": "發燒、黃疸、腹水" },
      { "key": "D", "text": "水腫、蛋白尿、高血脂" }
    ],
    "answer": "B",
    "explanation": "RCC 的 classic triad 為血尿、側腹痛、腹部腫塊（但臨床上並不一定三者都出現）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列何者最符合 RCC 的副腫瘤症候群（paraneoplastic syndrome）之一？",
    "options": [
      { "key": "A", "text": "多血症（polycythemia）" },
      { "key": "B", "text": "重度低白蛋白血症必發" },
      { "key": "C", "text": "甲狀腺功能低下必發" },
      { "key": "D", "text": "尿酸一定下降" }
    ],
    "answer": "A",
    "explanation": "RCC 可分泌 EPO 導致多血症，也可能造成高鈣血症（PTHrP）、高血壓（renin）、肝功能異常（Stauffer syndrome）等副腫瘤表現。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列何者為 RCC 的重要危險因子？",
    "options": [
      { "key": "A", "text": "吸菸" },
      { "key": "B", "text": "低鹽飲食" },
      { "key": "C", "text": "規則運動" },
      { "key": "D", "text": "高纖飲食" }
    ],
    "answer": "A",
    "explanation": "RCC 重要風險因子包含吸菸、肥胖、高血壓、特定遺傳症候群（如 VHL）等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列哪一種影像檢查最常用於評估腎腫塊並協助分期（staging）？",
    "options": [
      { "key": "A", "text": "對比增強腹部 CT" },
      { "key": "B", "text": "單純 KUB X-ray" },
      { "key": "C", "text": "腎臟核醫 DMSA" },
      { "key": "D", "text": "胸部超音波" }
    ],
    "answer": "A",
    "explanation": "對比增強 CT 是評估腎腫塊特性與分期常用的一線工具（若對比禁忌可考慮 MRI 等替代）。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜A 概論" },
    "stem": "有關中樞神經感染單純疹病毒（HSV）診斷工具中的 HSV 腦脊髓液 PCR，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "敏感性（sensitivity）及專一性（specificity）都超過 90%" },
      { "key": "B", "text": "在發病 72 小時內，腦脊髓液 HSV PCR 有可能呈現陰性" },
      { "key": "C", "text": "腦脊髓液 HSV PCR 的陽性率會隨病程逐漸降低，發病超過 14 天者約僅 20% 仍呈陽性" },
      { "key": "D", "text": "抗病毒治療會使 HSV PCR 陽性率大幅下降，治療 3 天後陽性率即低於 10%" }
    ],
    "answer": "D",
    "explanation": "HSV CSF PCR 早期（<72 小時）可偽陰性；病程較久（約 8–14 天後）才會逐步下降，>14 天仍可能有部分患者維持陽性。單純治療 3 天就降到 <10% 並不正確。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜結核性腦膜炎" },
    "stem": "有關結核性腦膜炎的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "腦脊髓液檢查通常會有淋巴球增多（lymphocytic pleocytosis，約 10–500 cells/µL）" },
      { "key": "B", "text": "腦脊髓液檢查通常葡萄糖濃度會下降（約 20–40 mg/dL）" },
      { "key": "C", "text": "文獻報告少於一半病人腦脊髓液 acid-fast stain 會呈陽性" },
      { "key": "D", "text": "腦脊髓液結核菌 PCR 已經取代培養，成為最主要診斷工具" }
    ],
    "answer": "D",
    "explanation": "TB meningitis 的 PCR 有助診斷，但培養仍是重要（含藥敏）工具，PCR 不能完全取代培養。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜細菌性腦膜炎（診斷）" },
    "stem": "針對細菌性腦膜炎病人的診斷，下列有關腦脊髓液（CSF）檢查之敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "超過一半病人的 CSF 會有 PMN 白血球增加至 >100 cells/µL 現象" },
      { "key": "B", "text": "超過一半病人的 CSF/serum glucose 比值 <0.4" },
      { "key": "C", "text": "超過一半病人的 CSF 細菌培養會是陽性" },
      { "key": "D", "text": "CSF Gram stain 幫助不大，只有約 20% 可以看到致病原" }
    ],
    "answer": "D",
    "explanation": "Gram stain 是細菌性腦膜炎的重要快速檢驗之一，敏感性常見可達約 60–80%，特異性也高；說只有約 20% 幫助不大是錯的。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜腦膜炎雙球菌" },
    "stem": "某新兵訓練中心爆發多名新兵發燒、頭痛、嘔吐、理學檢查為頸部僵硬、出血性皮疹，腦脊髓液染色為革蘭氏陰性雙球菌。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "病人必須採負壓隔離（空氣隔離防護措施）" },
      { "key": "B", "text": "該病原菌是 Neisseria meningitidis" },
      { "key": "C", "text": "抗生素投藥 24 小時後，一般病人即不具有傳染性" },
      { "key": "D", "text": "治療藥物為 penicillin 或 ceftriaxone" }
    ],
    "answer": "A",
    "explanation": "腦膜炎雙球菌主要採飛沫防護（droplet precautions）；不需要負壓空氣隔離。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜細菌性腦膜炎" },
    "stem": "關於 bacterial meningitis 的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "CSF opening pressure 常大於 180 mmH2O" },
      { "key": "B", "text": "CSF/serum glucose ratio 大於 0.4" },
      { "key": "C", "text": "CSF protein 上升，常大於 45 mg/dL" },
      { "key": "D", "text": "CSF Gram stain 陽性率可 >50%" }
    ],
    "answer": "B",
    "explanation": "細菌性腦膜炎常見 CSF/serum glucose ratio 降低（常 <0.4），因此「大於 0.4」是錯的。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜蜂窩性組織炎" },
    "stem": "關於蜂窩性組織炎的致病菌描述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "經由切片（punch biopsy）培養陽性結果的機會可高達 70%" },
      { "key": "B", "text": "鏈球菌（streptococci）在下肢循環不良的病人常導致反覆感染" },
      { "key": "C", "text": "被貓狗咬傷易產生厭氧菌相關感染" },
      { "key": "D", "text": "綠膿桿菌可見於被鐵釘穿刺傷造成的傷口感染" }
    ],
    "answer": "A",
    "explanation": "蜂窩性組織炎用切片或針吸找菌的陽性率普遍偏低（約 20–30%），臨床不常靠此常規檢出致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜水泡/大水泡皮損" },
    "stem": "當皮膚軟組織感染合併水泡（vesicles or bullae）時，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "Coxsackievirus 常好發於小孩，小水泡多分布於手腳或嘴巴" },
      { "key": "B", "text": "Vibrio vulnificus 的危險因子為接觸淡水" },
      { "key": "C", "text": "Staphylococcal scalded skin syndrome 與 toxic epidermal necrolysis 外觀不易分辨，切片可助鑑別" },
      { "key": "D", "text": "水痘若呈紅黑色、紅腫快速蔓延或合併局部感覺異常，需把壞死性筋膜炎列入鑑別" }
    ],
    "answer": "B",
    "explanation": "Vibrio vulnificus 的高風險暴露典型是海水/海產相關，而不是淡水。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus" },
    "stem": "40 歲男性有肝硬化病史。夏天在海邊釣魚時被魚刺刺傷左腳，隔天左腳紅腫熱痛，出現紫紅色水泡且有休克現象。最可能之致病菌為何？",
    "options": [
      { "key": "A", "text": "Staphylococcus aureus" },
      { "key": "B", "text": "Streptococcus pyogenes" },
      { "key": "C", "text": "Pseudomonas aeruginosa" },
      { "key": "D", "text": "Vibrio vulnificus" }
    ],
    "answer": "D",
    "explanation": "肝硬化 + 海水暴露/海產相關傷口 + 快速進展水泡與休克，是 Vibrio vulnificus 的典型高風險情境。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus（治療）" },
    "stem": "承上題，下列何種抗生素治療對該病人最為恰當？",
    "options": [
      { "key": "A", "text": "Vancomycin + gentamicin" },
      { "key": "B", "text": "Clindamycin + penicillin" },
      { "key": "C", "text": "Ceftazidime + tetracycline" },
      { "key": "D", "text": "Cefazolin + amikacin" }
    ],
    "answer": "C",
    "explanation": "Vibrio vulnificus 建議以可涵蓋該菌的第三代頭孢菌素（如 ceftazidime）合併 tetracycline 類，以兼顧療效並抑制毒素相關嚴重病程。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜經驗性用藥" },
    "stem": "皮膚軟組織感染之經驗性抗微生物製劑選擇（無藥物過敏、無其他慢性病），下列何者作為第一線治療最不恰當？",
    "options": [
      { "key": "A", "text": "狗咬傷：amoxicillin-clavulanate 或 ampicillin-sulbactam" },
      { "key": "B", "text": "帶狀疱疹（免疫正常，>50 歲）：acyclovir" },
      { "key": "C", "text": "蜂窩性組織炎（staphylococcal or streptococcal）：vancomycin" },
      { "key": "D", "text": "壞死性筋膜炎：可同時涵蓋嗜氧菌與厭氧菌的抗生素組合" }
    ],
    "answer": "C",
    "explanation": "Vancomycin 通常保留於 MRSA 或高度抗藥性疑慮；一般單純蜂窩性組織炎（以 MSSA/鏈球菌為主）不會以 vancomycin 作第一線。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜接觸史與病原" },
    "stem": "引起皮膚軟組織感染的病原菌可能有不同接觸史或表現形態，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "Pseudomonas：hot-tub folliculitis" },
      { "key": "B", "text": "Streptococcus pyogenes：lymphangitis" },
      { "key": "C", "text": "Treponema pallidum：露珠狀水泡（dewdrop vesicle）" },
      { "key": "D", "text": "HSV-1：唇邊水泡" }
    ],
    "answer": "C",
    "explanation": "「露珠狀水泡」典型描述較偏向水痘/帶狀疱疹等疱疹病毒皮疹；梅毒常見為無痛性潰瘍或後續廣泛皮疹，非此典型表現。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜壞死性筋膜炎（臨床）" },
    "stem": "肝硬化病人釣魚時腳被牡蠣殼割傷後，紅腫迅速擴散並出現水泡與組織壞死且發燒發冷。關於該病人疾病，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "需詳細詢問病人接觸史，包含海水暴露史" },
      { "key": "B", "text": "若無海水暴露史，即可排除壞死性筋膜炎" },
      { "key": "C", "text": "食用未煮熟的海鮮也有可能引發嚴重軟組織感染" },
      { "key": "D", "text": "若皮膚未明顯發紅但病人表示劇烈疼痛，仍不可排除壞死性筋膜炎" }
    ],
    "answer": "B",
    "explanation": "壞死性筋膜炎的關鍵是臨床表現（進展快、疼痛與外觀不成比例等），不是只有海水暴露才會發生；無海水暴露也不能排除。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜壞死性筋膜炎（處置）" },
    "stem": "承上題，關於病人處置，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "可用影像（如 CT）評估病灶範圍，但不應延誤關鍵處置" },
      { "key": "B", "text": "儘快留取感染部位檢體並給予適當抗生素" },
      { "key": "C", "text": "聯絡外科進行清創處理" },
      { "key": "D", "text": "若病人最後死亡，主要與細菌侵犯組織有關，與毒素無關" }
    ],
    "answer": "D",
    "explanation": "壞死性筋膜炎（尤其某些菌種）可有嚴重毒素相關全身反應與休克；死亡機轉不僅是局部組織侵犯。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus（海鮮暴露）" },
    "stem": "70 歲肝硬化病人，近來自行剝生蠔食用後出現發燒兩天，今日出現水泡且到院時血壓 90/50 mmHg。最可能感染之病原菌為何？",
    "options": [
      { "key": "A", "text": "Staphylococcus aureus" },
      { "key": "B", "text": "Vibrio vulnificus" },
      { "key": "C", "text": "Group A streptococcus" },
      { "key": "D", "text": "Klebsiella pneumoniae" }
    ],
    "answer": "B",
    "explanation": "肝硬化 + 生蠔/海鮮暴露 + 水泡性皮膚病灶與休克，非常典型指向 Vibrio vulnificus。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜CAUTI" },
    "stem": "導管長期置放是造成醫療照護相關感染的常見危險因子。導尿管置放後每日發生尿路感染的機會約為多少？",
    "options": [
      { "key": "A", "text": "0.03%–0.07%" },
      { "key": "B", "text": "0.3%–0.7%" },
      { "key": "C", "text": "3%–7%" },
      { "key": "D", "text": "30%–70%" }
    ],
    "answer": "C",
    "explanation": "CAUTI 的風險會隨留置天數上升；經典數字是「每日約 3–7%」的感染風險。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜重症腹瀉菌血症（題組）" },
    "stem": "80 歲肝硬化病人因腹痛、腹瀉、發燒住院，血壓偏低且有黃疸，糞便與血液培養均長出 Campylobacter jejuni。在藥敏報告出來前，何者為最適當的抗生素治療？",
    "options": [
      { "key": "A", "text": "Trimethoprim-sulfamethoxazole" },
      { "key": "B", "text": "Metronidazole" },
      { "key": "C", "text": "Ampicillin" },
      { "key": "D", "text": "Carbapenem" }
    ],
    "answer": "D",
    "explanation": "此題情境為重症且合併菌血症/敗血傾向，經驗性用藥需以涵蓋力更足的方案優先；ampicillin 可能因抗藥性與嚴重度而不適合作為首選。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜旅行者腹瀉/食物中毒（觀念題）" },
    "stem": "關於細菌性食物中毒與旅行者腹瀉（traveler’s diarrhea）的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "潛伏期最短的致病菌常見為 Staphylococcus aureus 與 Bacillus cereus（嘔吐型）" },
      { "key": "B", "text": "Shigella spp 只能經由污染的飲水與食物傳播，不會人對人直接傳染" },
      { "key": "C", "text": "Shigella spp、Entamoeba histolytica、Giardia lamblia 的感染劑量通常遠低於 Vibrio cholerae" },
      { "key": "D", "text": "霍亂弧菌腹瀉主要因腸毒素，糞便多為米湯樣且很少白血球" }
    ],
    "answer": "B",
    "explanation": "Shigella 也可透過糞口途徑人傳人（尤其在密集生活環境），不只靠食物/飲水。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜CAUTI（預防）" },
    "stem": "下列關於導管相關尿路感染（CAUTI）的敘述，何者正確？",
    "options": [
      { "key": "A", "text": "常規使用抗生素塗抹於尿道口是預防 CAUTI 最有效的措施" },
      { "key": "B", "text": "常規口服抗生素預防 CAUTI 是實證強烈建議的措施" },
      { "key": "C", "text": "CAUTI 的發生與導尿管材質品質關係最大" },
      { "key": "D", "text": "經尿管沖洗膀胱，即使加入抗生素，仍可能增加 CAUTI 的機會" }
    ],
    "answer": "D",
    "explanation": "常規局部/全身抗生素預防或膀胱灌洗並非標準預防策略，反而可能增加風險；核心仍是減少不必要置管、無菌置放與及早移除。"
  },

{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜無症狀菌尿" },
  "stem": "下列何者屬於「無症狀菌尿（asymptomatic bacteriuria）」通常建議治療的族群？",
  "options": [
    { "key": "A", "text": "健康非孕女性" },
    { "key": "B", "text": "長照機構住民但無泌尿症狀" },
    { "key": "C", "text": "孕婦" },
    { "key": "D", "text": "老年男性僅有混濁尿" }
  ],
  "answer": "C",
  "explanation": "無症狀菌尿一般不治療；例外最重要的是孕婦（以及預計進行可能造成黏膜出血的泌尿道侵入性處置）。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜無症狀菌尿" },
  "stem": "下列何者為「無症狀菌尿」不建議常規篩檢與治療的主要理由？",
  "options": [
    { "key": "A", "text": "會增加抗藥性與藥物副作用，且多數不改善預後" },
    { "key": "B", "text": "因為無症狀菌尿多為病毒造成" },
    { "key": "C", "text": "治療會造成永久腎衰竭" },
    { "key": "D", "text": "治療會誘發敗血症" }
  ],
  "answer": "A",
  "explanation": "大多數族群治療無症狀菌尿不改善臨床結果，反而增加抗生素副作用與抗藥性壓力。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜腎盂腎炎" },
  "stem": "關於急性腎盂腎炎（pyelonephritis）的臨床表現，下列何者最典型？",
  "options": [
    { "key": "A", "text": "頻尿、急尿但無發燒" },
    { "key": "B", "text": "發燒、寒顫合併肋脊角叩擊痛（CVA tenderness）" },
    { "key": "C", "text": "單純尿液混濁但無症狀" },
    { "key": "D", "text": "只有蛋白尿" }
  ],
  "answer": "B",
  "explanation": "腎盂腎炎屬上泌尿道感染，常見全身症狀（發燒/寒顫）與 CVA tenderness。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜複雜性 UTI" },
  "stem": "下列何者最符合複雜性 UTI（complicated UTI）的情境？",
  "options": [
    { "key": "A", "text": "健康非孕女性單純膀胱炎" },
    { "key": "B", "text": "男性 UTI" },
    { "key": "C", "text": "症狀輕微就一定是單純" },
    { "key": "D", "text": "尿培養陰性" }
  ],
  "answer": "B",
  "explanation": "男性、尿路結構/功能異常、阻塞、導尿管、免疫低下、孕婦等通常視為複雜性 UTI，需要更完整評估與療程。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜導管相關" },
  "stem": "關於導管相關尿路感染（CAUTI）的預防，下列何者最正確？",
  "options": [
    { "key": "A", "text": "常規使用預防性抗生素最有效" },
    { "key": "B", "text": "最重要是避免不必要置管並盡早移除" },
    { "key": "C", "text": "每日以抗生素溶液沖洗導尿管" },
    { "key": "D", "text": "只要尿液混濁就需更換導尿管並治療" }
  ],
  "answer": "B",
  "explanation": "CAUTI 核心是「減少置管天數」：避免不必要留置、無菌置放、維持封閉引流系統、盡早移除。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜Clostridioides difficile" },
  "stem": "病人近期使用抗生素後出現水樣腹瀉，最需要優先考慮哪一種病原？",
  "options": [
    { "key": "A", "text": "Vibrio cholerae" },
    { "key": "B", "text": "Clostridioides difficile" },
    { "key": "C", "text": "Giardia lamblia" },
    { "key": "D", "text": "Norovirus" }
  ],
  "answer": "B",
  "explanation": "抗生素相關腹瀉的重要鑑別是 C. difficile（偽膜性腸炎），需依臨床與糞便檢驗評估並及早治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜EHEC" },
  "stem": "疑似腸出血性大腸桿菌（EHEC）感染之血便病人，下列何者最不建議？",
  "options": [
    { "key": "A", "text": "補充水分與支持性療法" },
    { "key": "B", "text": "避免止瀉藥" },
    { "key": "C", "text": "例行性使用抗生素" },
    { "key": "D", "text": "監測溶血尿毒症候群（HUS）徵象" }
  ],
  "answer": "C",
  "explanation": "EHEC 相關血便需小心 HUS；抗生素與止瀉藥可能增加風險，因此多以支持性療法為主並密切追蹤。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜霍亂" },
  "stem": "霍亂（cholera）最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "高燒合併血便" },
    { "key": "B", "text": "米湯樣大量水瀉，脫水明顯" },
    { "key": "C", "text": "腹瀉伴大量白血球與膿便" },
    { "key": "D", "text": "腹瀉伴顯著黃疸" }
  ],
  "answer": "B",
  "explanation": "霍亂腸毒素造成分泌性水瀉，典型是米湯樣大量腹瀉與嚴重脫水；治療核心是快速補液。"
},
{
  "id": "MED3_RENAL_INF_ORI_ARTHR_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜己 感染性關節炎" },
  "stem": "成人急性單一大關節紅腫熱痛合併發燒，下列何者是最重要的下一步？",
  "options": [
    { "key": "A", "text": "先給 NSAIDs 觀察 48 小時" },
    { "key": "B", "text": "立即抽取關節液做檢驗（cell count、Gram stain、culture）" },
    { "key": "C", "text": "只照 X 光即可排除感染" },
    { "key": "D", "text": "等血液培養結果出來再處理" }
  ],
  "answer": "B",
  "explanation": "感染性關節炎屬急症，關節液檢驗與培養是診斷關鍵，並需及早引流與抗生素治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_ARTHR_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜己 感染性關節炎" },
  "stem": "感染性關節炎之關節液分析，下列哪一項最支持細菌性關節炎？",
  "options": [
    { "key": "A", "text": "WBC < 2,000/µL 且以單核球為主" },
    { "key": "B", "text": "WBC > 50,000/µL 且以多核球為主" },
    { "key": "C", "text": "只有尿酸結晶" },
    { "key": "D", "text": "葡萄糖正常且蛋白極低" }
  ],
  "answer": "B",
  "explanation": "細菌性關節炎常見關節液高 WBC（常 >50,000/µL）且 PMN 為主；仍需配合 Gram stain/culture。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

  {
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜流感" },
  "stem": "下列有關流感之敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "流行性感冒病毒屬於 RNA 病毒" },
    { "key": "B", "text": "主要傳播方式是透過飛沫傳染與接觸傳染" },
    { "key": "C", "text": "免疫缺損病人及兒童可傳染期較成人病例為長" },
    { "key": "D", "text": "流感快篩陰性，即可排除流感" }
  ],
  "answer": "D",
  "explanation": "流感快篩的敏感度有限（臨床常見約 50–70%），陰性結果不能完全排除流感；若臨床高度懷疑（典型症狀且在流行季），仍應考慮以 PCR 確認或依臨床情境給予抗病毒治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜隔離與特殊防護" },
  "stem": "下列那一個致病菌目前沒有效的抗微生物製劑治療，且必須進行特殊隔離，以免傳播給其他人？",
  "options": [
    { "key": "A", "text": "嚴重急性呼吸道症候群（severe acute respiratory syndrome）" },
    { "key": "B", "text": "吸入型炭疽病（anthrax）" },
    { "key": "C", "text": "漢生病（Hansen's disease）" },
    { "key": "D", "text": "流行性感冒" }
  ],
  "answer": "A",
  "explanation": "SARS 為病毒性呼吸道感染，缺乏「有效抗微生物製劑」可直接根治，且具院內傳播風險，需要嚴格感染管制（以飛沫為主，侵入性呼吸道處置時需特別注意氣溶膠風險）。吸入型炭疽不典型人傳人；漢生病傳染力低且可治療；流感以飛沫/接觸隔離為主。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜流感疫苗" },
  "stem": "下列有關注射型流感疫苗之敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "採肌肉注射" },
    { "key": "B", "text": "年齡 6 個月以下者，不予接種" },
    { "key": "C", "text": "孕婦及免疫不全病人屬於禁忌，不應接種" },
    { "key": "D", "text": "已知對「蛋」之蛋白質過敏者，不予接種" }
  ],
  "answer": "C",
  "explanation": "注射型流感疫苗為肌肉注射，且 6 個月以下不接種；孕婦與免疫不全者並非禁忌，反而常屬高風險族群、一般建議接種以降低重症風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜Infectious mononucleosis 鑑別" },
  "stem": "20 歲男性大學生，持續發燒 10 天合併頭痛、肌肉疼痛及喉嚨痛。身體診察有頸部和鼠蹊淋巴腺腫大及軀幹斑丘疹。WBC 4,200/mL，分類：多核球 35%、淋巴球 45%、單核球 15%、非典型淋巴球 5%。GOT 56、GPT 60。最不需要選擇下列何種檢驗？",
  "options": [
    { "key": "A", "text": "HIV test（human immunodeficiency virus I & II）" },
    { "key": "B", "text": "CMV IgM（cytomegalovirus IgM）" },
    { "key": "C", "text": "EB VCA IgM（Epstein–Barr viral capsid antigen IgM）" },
    { "key": "D", "text": "measles IgM" }
  ],
  "answer": "D",
  "explanation": "此臨床圖像（發燒、咽喉痛、淋巴結腫大、皮疹、輕度轉氨酶上升、可見非典型淋巴球）較符合 infectious mononucleosis 類群，常見病原包含 EBV、CMV 與急性 HIV；相較之下 measles IgM 並非優先檢驗。"
},
{
  "id": "MED3_RENAL_INF_ORI_MEASLES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜麻疹" },
  "stem": "1 歲大女嬰出現發燒、咳嗽、流鼻水及結膜炎，發燒後 3–4 天口腔出現柯氏斑點（Koplik's spots），最有可能診斷為何？",
  "options": [
    { "key": "A", "text": "嬰兒玫瑰疹" },
    { "key": "B", "text": "猩紅熱" },
    { "key": "C", "text": "川崎氏症" },
    { "key": "D", "text": "麻疹" }
  ],
  "answer": "D",
  "explanation": "麻疹典型前驅症狀為發燒、咳嗽、鼻炎（coryza）、結膜炎（3C），隨後可見口腔黏膜 Koplik spots，之後出現由頭頸往下的紅疹。"
},
{
  "id": "MED3_RENAL_INF_ORI_MEASLES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜麻疹" },
  "stem": "下列有關麻疹的敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "麻疹病毒是一種 RNA 病毒，主要藉由飛沫傳染，亦可經由接觸傳染" },
    { "key": "B", "text": "發病初期的症狀以發燒、鼻炎、結膜炎以及咳嗽為主" },
    { "key": "C", "text": "發病 2 至 4 天後，皮膚上會出現柯氏斑點（Koplik's spots）以及紅疹，由頭部向下移至軀幹" },
    { "key": "D", "text": "施打 MMR 疫苗可以用來預防麻疹、流行性腮腺炎以及德國麻疹" }
  ],
  "answer": "C",
  "explanation": "Koplik's spots 是「口腔黏膜」病灶，通常在出疹前出現；紅疹才是由頭頸往下蔓延。把 Koplik spots 說成在皮膚上出現是不正確的。"
},
{
  "id": "MED3_RENAL_INF_ORI_HERPES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜疱疹相關病毒" },
  "stem": "下列有關皰疹相關病毒的敘述，何者正確？",
  "options": [
    { "key": "A", "text": "免疫正常的人發生過皮膚性帶狀皰疹（herpes zoster），大於 10% 會反覆發作" },
    { "key": "B", "text": "未曾施打水痘（chickenpox）疫苗且未曾感染過水痘者，在接觸水痘病人後有小於 40% 會被感染" },
    { "key": "C", "text": "感染性單核細胞增多症（infectious mononucleosis）的最常見症狀是發燒、喉嚨痛、淋巴結腫大" },
    { "key": "D", "text": "在年輕人，感染性單核細胞增多症的潛伏期為 5–10 天" }
  ],
  "answer": "C",
  "explanation": "感染性單核球增多症典型三聯徵為發燒、咽炎與淋巴結腫大。其潛伏期通常較長（常以數週計），而水痘接觸後的二代傳播率一般不低。"
},
{
  "id": "MED3_RENAL_INF_ORI_RABIES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜狂犬病暴露後預防（PEP）" },
  "stem": "下列「狂犬病暴露後的疫苗注射」及建議時間，何者正確？",
  "options": [
    { "key": "A", "text": "第 0、3、7、14、28 天，共 5 次" },
    { "key": "B", "text": "第 0、7、14、28 天，共 4 次" },
    { "key": "C", "text": "第 0、7、28 天，共 3 次" },
    { "key": "D", "text": "第 0、14、28 天，共 3 次" }
  ],
  "answer": "A",
  "explanation": "狂犬病暴露後預防（PEP）常見考法為疫苗時程：第 0、3、7、14、28 天共 5 劑（並依暴露風險評估是否需要在傷口周圍注射 RIG）。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Acyclovir" },
  "stem": "下列何者最符合 acyclovir 的臨床使用與副作用描述？",
  "options": [
    { "key": "A", "text": "主要治療 CMV；常見骨髓抑制" },
    { "key": "B", "text": "主要治療 HSV/VZV；高劑量或靜脈使用可造成結晶性腎病變" },
    { "key": "C", "text": "主要治療流感；常見肌肉毒性" },
    { "key": "D", "text": "主要治療 HIV；常見乳酸中毒" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 常用於 HSV/VZV；IV 或高劑量可能造成結晶性腎損傷（注意補液、腎功能調整）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Ganciclovir/Valganciclovir" },
  "stem": "Ganciclovir（或 valganciclovir）最典型的適應症與重要副作用組合為何？",
  "options": [
    { "key": "A", "text": "治療 CMV；骨髓抑制（neutropenia）" },
    { "key": "B", "text": "治療流感；嚴重肝衰竭" },
    { "key": "C", "text": "治療 HSV；嚴重耳毒性" },
    { "key": "D", "text": "治療 HBV；甲狀腺毒性" }
  ],
  "answer": "A",
  "explanation": "Ganciclovir/valganciclovir 常用於 CMV（如 CMV retinitis 等），重要副作用是骨髓抑制（特別是 neutropenia、thrombocytopenia）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Foscarnet" },
  "stem": "Foscarnet 的臨床定位與典型毒性，下列何者最正確？",
  "options": [
    { "key": "A", "text": "用於抗藥 HSV/CMV；腎毒性與電解質異常（如低鈣）" },
    { "key": "B", "text": "用於流感；骨髓抑制" },
    { "key": "C", "text": "用於 HBV；嚴重貧血" },
    { "key": "D", "text": "用於 RSV；心肌毒性" }
  ],
  "answer": "A",
  "explanation": "Foscarnet 可用於 ganciclovir-resistant CMV 或 acyclovir-resistant HSV；重要不良反應為腎毒性及電解質異常（低 Ca/Mg/K 等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜檢驗策略" },
  "stem": "HIV 感染的初步篩檢與確認，下列何者最符合一般臨床流程概念？",
  "options": [
    { "key": "A", "text": "只做一次 HIV 抗體快篩陽性即可直接診斷 HIV 感染" },
    { "key": "B", "text": "先做篩檢試驗（如 Ag/Ab），陽性再做確認試驗（分型/補充檢驗或核酸檢測）" },
    { "key": "C", "text": "HIV PCR 只能在 AIDS 才會陽性" },
    { "key": "D", "text": "陰性結果永遠可排除（不需考慮 window period）" }
  ],
  "answer": "B",
  "explanation": "臨床多採「先篩檢、後確認」；並需考量暴露時間與檢驗 window period，必要時重複檢驗或做核酸檢測。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜PJP 預防" },
  "stem": "下列何者最符合 Pneumocystis jirovecii pneumonia（PJP）預防用藥的典型指徵與首選？",
  "options": [
    { "key": "A", "text": "CD4 <200/µL；首選 TMP-SMX" },
    { "key": "B", "text": "CD4 <500/µL；首選 azithromycin" },
    { "key": "C", "text": "CD4 <50/µL；首選 isoniazid" },
    { "key": "D", "text": "任何 HIV 感染者都需終身 TMP-SMX" }
  ],
  "answer": "A",
  "explanation": "PJP 預防典型門檻為 CD4 <200/µL（或特定高風險情境），首選 TMP-SMX。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜Toxoplasma 預防" },
  "stem": "HIV 病人若 toxoplasma IgG 陽性且 CD4 過低，最典型需要預防的機會性感染為何？",
  "options": [
    { "key": "A", "text": "Toxoplasma encephalitis（腦炎）" },
    { "key": "B", "text": "流感肺炎" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "Toxoplasma IgG 陽性代表既往感染；在嚴重免疫抑制（典型 CD4 <100/µL）時有再活化風險，需考慮預防（常用 TMP-SMX）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜MAC 預防" },
  "stem": "HIV 病人 CD4 極低時（典型 <50/µL）最需要注意/預防的嚴重散播性感染之一為何？",
  "options": [
    { "key": "A", "text": "Mycobacterium avium complex（MAC）" },
    { "key": "B", "text": "流行性感冒" },
    { "key": "C", "text": "A 型肝炎" },
    { "key": "D", "text": "單純性膀胱炎" }
  ],
  "answer": "A",
  "explanation": "CD4 <50/µL 時 MAC 散播性感染風險顯著上升；是否需要預防用藥取決於是否已有效 ART 與臨床策略，但此門檻與 MAC 是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜CMV" },
  "stem": "AIDS 病人出現視力模糊、飛蚊症，眼底檢查見網膜出血與壞死（典型“pizza pie”外觀），最可能之病原與治療藥物組合為何？",
  "options": [
    { "key": "A", "text": "HSV；acyclovir" },
    { "key": "B", "text": "CMV；ganciclovir/valganciclovir" },
    { "key": "C", "text": "VZV；oseltamivir" },
    { "key": "D", "text": "EBV；amoxicillin-clavulanate" }
  ],
  "answer": "B",
  "explanation": "AIDS 低 CD4 時可見 CMV retinitis；治療以 ganciclovir/valganciclovir（或依抗藥性與狀況選 foscarnet 等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜Cryptococcus" },
  "stem": "HIV 病人亞急性頭痛、發燒，腰椎穿刺顯示 opening pressure 上升，最需要考慮哪一種黴菌性腦膜炎？",
  "options": [
    { "key": "A", "text": "Cryptococcus neoformans" },
    { "key": "B", "text": "Candida albicans" },
    { "key": "C", "text": "Aspergillus fumigatus" },
    { "key": "D", "text": "Dermatophyte" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在 AIDS 常造成亞急性腦膜炎，典型可見顱內壓上升，診斷可用 CrAg（cryptococcal antigen）等。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜PJP 臨床" },
  "stem": "HIV 病人漸進性呼吸困難、乾咳、低氧，胸部影像常見雙側瀰漫性間質性浸潤。最可能診斷為何？",
  "options": [
    { "key": "A", "text": "PJP（Pneumocystis jirovecii pneumonia）" },
    { "key": "B", "text": "典型肺炎鏈球菌肺炎" },
    { "key": "C", "text": "肺結核必然" },
    { "key": "D", "text": "單純急性支氣管炎" }
  ],
  "answer": "A",
  "explanation": "PJP 常表現為亞急性/漸進性呼吸症狀、低氧，影像可呈雙側瀰漫性間質性浸潤（或磨玻璃）。治療多以 TMP-SMX，嚴重低氧時加用類固醇。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜ART 原則" },
  "stem": "啟動 ART 後病毒量下降、CD4 回升的主要臨床意義，下列何者最正確？",
  "options": [
    { "key": "A", "text": "代表可立即停藥以避免副作用" },
    { "key": "B", "text": "可降低機會性感染與傳播風險，但需持續治療與追蹤" },
    { "key": "C", "text": "代表 HIV 已被根除，不需再追蹤" },
    { "key": "D", "text": "只要病毒量不可偵測就不會再有任何併發症風險" }
  ],
  "answer": "B",
  "explanation": "有效 ART 可降低 OI 與死亡率並顯著降低傳播風險，但仍需長期持續治療與規律追蹤（抗藥性、共病、疫苗與預防策略等）。"
},

  {
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida（念珠菌）" },
  "stem": "下列何者最符合 Candida 感染的典型臨床概念？",
  "options": [
    { "key": "A", "text": "健康人血培長出 Candida 多為污染，可忽略" },
    { "key": "B", "text": "中心靜脈導管、TPN、廣效抗生素為常見危險因子" },
    { "key": "C", "text": "Candida 只會造成皮膚表淺感染，不會菌血症" },
    { "key": "D", "text": "Candida 感染與免疫狀態無關" }
  ],
  "answer": "B",
  "explanation": "侵襲性 Candida（含 candidemia）常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫抑制相關；血培長出 Candida 通常需視為重要事件。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus（曲霉）" },
  "stem": "侵襲性 Aspergillus 感染最常侵犯的器官為何？",
  "options": [
    { "key": "A", "text": "肺" },
    { "key": "B", "text": "膀胱" },
    { "key": "C", "text": "甲狀腺" },
    { "key": "D", "text": "胰臟" }
  ],
  "answer": "A",
  "explanation": "侵襲性 aspergillosis 多由吸入孢子引起，最常首先侵犯肺部，免疫低下者可血行散播至腦等器官。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus（治療）" },
  "stem": "侵襲性 aspergillosis 的第一線治療藥物，下列何者最典型？",
  "options": [
    { "key": "A", "text": "Fluconazole" },
    { "key": "B", "text": "Voriconazole" },
    { "key": "C", "text": "Acyclovir" },
    { "key": "D", "text": "Oseltamivir" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 第一線常為 voriconazole（或依病況/藥物交互作用選擇其他抗黴菌方案）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Mucormycosis（接合菌）" },
  "stem": "糖尿病酮酸中毒（DKA）病人出現鼻竇炎、顏面腫痛與黑色壞死痂皮（eschar），最需要考慮哪一種致命黴菌感染？",
  "options": [
    { "key": "A", "text": "Candida" },
    { "key": "B", "text": "Mucormycosis（zygomycosis）" },
    { "key": "C", "text": "Cryptococcus" },
    { "key": "D", "text": "Pneumocystis" }
  ],
  "answer": "B",
  "explanation": "DKA + 鼻顱（rhino-orbital-cerebral）侵犯 + 黑色壞死痂皮是 mucormycosis 經典情境，需緊急手術清創合併 amphotericin B 等治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus（診斷）" },
  "stem": "懷疑 cryptococcal meningitis 時，下列何者最有助於快速診斷？",
  "options": [
    { "key": "A", "text": "CSF cryptococcal antigen（CrAg）" },
    { "key": "B", "text": "糞便培養" },
    { "key": "C", "text": "尿液抗原（Legionella）" },
    { "key": "D", "text": "咽喉拭子快速抗原" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 腦膜炎可用 CSF（或血清）cryptococcal antigen 快速輔助診斷；也可見 India ink 等，但 CrAg 是重要快速工具。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Pneumocystis" },
  "stem": "Pneumocystis jirovecii pneumonia（PJP）最典型好發於下列哪一族群？",
  "options": [
    { "key": "A", "text": "健康成人急性支氣管炎" },
    { "key": "B", "text": "免疫低下者（如 HIV CD4 很低、移植、長期高劑量類固醇）" },
    { "key": "C", "text": "單純高血壓病人" },
    { "key": "D", "text": "單純胃食道逆流" }
  ],
  "answer": "B",
  "explanation": "PJP 為典型機會性感染，常見於嚴重免疫抑制族群。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜瘧疾（概念）" },
  "stem": "瘧疾（malaria）最典型的傳播媒介為何？",
  "options": [
    { "key": "A", "text": "Aedes 蚊" },
    { "key": "B", "text": "Anopheles 雌蚊" },
    { "key": "C", "text": "Culex 蚊" },
    { "key": "D", "text": "蜱（tick）" }
  ],
  "answer": "B",
  "explanation": "瘧疾由 Anopheles 雌蚊傳播，是基本寄生蟲學常考點；Aedes 典型為登革熱等。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜瘧疾（嚴重型）" },
  "stem": "下列哪一種瘧原蟲最容易造成重症瘧疾（如腦性瘧疾）？",
  "options": [
    { "key": "A", "text": "Plasmodium falciparum" },
    { "key": "B", "text": "Plasmodium vivax" },
    { "key": "C", "text": "Plasmodium ovale" },
    { "key": "D", "text": "Plasmodium malariae" }
  ],
  "answer": "A",
  "explanation": "P. falciparum 與重症、腦性瘧疾風險最高相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜瘧疾（診斷）" },
  "stem": "懷疑瘧疾時，下列哪一項是最經典且關鍵的診斷檢查？",
  "options": [
    { "key": "A", "text": "糞便培養" },
    { "key": "B", "text": "厚薄血片（thick/thin smear）找瘧原蟲" },
    { "key": "C", "text": "尿液抗原" },
    { "key": "D", "text": "CSF PCR" }
  ],
  "answer": "B",
  "explanation": "瘧疾診斷經典為厚薄血片找寄生蟲並判定種類與寄生蟲量；快速檢驗可輔助，但血片仍是關鍵。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜登革熱（鑑別概念）" },
  "stem": "熱帶旅遊返國後出現發燒、頭痛、肌肉痛與皮疹，合併血小板下降。下列何者最符合登革熱的典型警示概念？",
  "options": [
    { "key": "A", "text": "一定合併黃疸與米湯樣腹瀉" },
    { "key": "B", "text": "可能出現出血傾向與血漿滲漏，需監測警示徵象" },
    { "key": "C", "text": "只要退燒即可，無需追蹤" },
    { "key": "D", "text": "登革熱主要由空氣傳播" }
  ],
  "answer": "B",
  "explanation": "登革熱重症與血漿滲漏/出血風險相關，臨床重點在液體管理與監測警示徵象；傳播媒介為 Aedes 蚊。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜阿米巴肝膿瘍" },
  "stem": "阿米巴肝膿瘍（amebic liver abscess）最典型的臨床描述為何？",
  "options": [
    { "key": "A", "text": "咳嗽與大量痰" },
    { "key": "B", "text": "右上腹痛、發燒，影像見單發肝膿瘍較常見" },
    { "key": "C", "text": "必然合併嚴重黃疸與米湯樣腹瀉" },
    { "key": "D", "text": "一定是多發、雙側肺膿瘍" }
  ],
  "answer": "B",
  "explanation": "E. histolytica 可造成肝膿瘍，常以右上腹痛與發燒表現；腸道症狀可能不明顯。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲｜Giardia（治療概念）" },
  "stem": "Giardia lamblia 感染的典型治療選項，下列何者最常見？",
  "options": [
    { "key": "A", "text": "Metronidazole（或相關 nitroimidazole）" },
    { "key": "B", "text": "Oseltamivir" },
    { "key": "C", "text": "Vancomycin" },
    { "key": "D", "text": "Acyclovir" }
  ],
  "answer": "A",
  "explanation": "Giardia 常以 metronidazole（或 tinidazole 等）治療；屬原蟲感染的常見處置。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "56 歲男性糖尿病人因胸部不適至急診，初步檢查：Cr 2.0 mg/dL、K+ 5.8 mEq/L、Na+ 139 mEq/L、Cl− 116 mEq/L、HCO3− 18 mEq/L、serum osmolality 290 mOsm/kg；尿中 Cr 12 mg/dL、K 9.6 mEq/dL、urine osmolality 580 mOsm/kg。病人最可能的診斷是：",
  "options": [
    { "key": "A", "text": "第二型腎小管酸血症（type 2 renal tubular acidosis）" },
    { "key": "B", "text": "Metformin 引發酸血症（metformin-related acidosis）" },
    { "key": "C", "text": "低腎素低醛固酮血症（hyporeninemic hypoaldosteronism，type 4 RTA）" },
    { "key": "D", "text": "糖尿病酮酸血症（diabetic ketoacidosis）" }
  ],
  "answer": "C",
  "explanation": "此例為高血鉀合併 non–anion gap metabolic acidosis，且提示鉀排泄不足（臨床上常用 TTKG 評估，<7 支持排鉀不足），指向 RAAS 軸調節不足的 type 4 RTA／低腎素低醛固酮血症。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "35 歲女性因最近血壓升高就診，初步生化檢查大致正常，惟血清鉀離子 2.5 mmol/L。下列哪一個診斷最不可能考慮？",
  "options": [
    { "key": "A", "text": "單側腎動脈狹窄（unilateral renal arterial stenosis）" },
    { "key": "B", "text": "服用甘草（licorice）" },
    { "key": "C", "text": "Gordon syndrome（pseudohypoaldosteronism type 2）" },
    { "key": "D", "text": "原發性醛固酮增多症（primary aldosteronism）" }
  ],
  "answer": "C",
  "explanation": "Gordon syndrome 的典型表現為 low-renin hypertension、**高血鉀**、高氯性代謝性酸中毒、腎功能多正常；與本題「高血壓 + 低血鉀」方向相反，因此最不可能。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "65 歲男性因嘔吐不止兩天至急診，脈搏 124/min、血壓 85/50 mmHg。血清電解質（mmol/L）：Na+ 132、K+ 2.9、Cl− 85。ABG：pH 7.49、PaCO2 47 mmHg、PaO2 90 mmHg、HCO3− 32 mmol/L。下列何者最為正確？",
  "options": [
    { "key": "A", "text": "血清滲透壓應該 >310 mOsm/kg H2O" },
    { "key": "B", "text": "尿液鉀離子應該 <10 mmol/L" },
    { "key": "C", "text": "尿液滲透壓應該 >500 mOsm/kg H2O" },
    { "key": "D", "text": "尿液氯離子應該 >20 mmol/L" }
  ],
  "answer": "C",
  "explanation": "嘔吐造成低容積→啟動 RAAS→留鈉、排鉀、排酸→代謝性鹼中毒；因低容積狀態尿液會高度濃縮，尿滲透壓上升（常 >500）。此外嘔吐/氯缺乏型代謝性鹼中毒通常尿氯偏低（<20），不支持選項 D。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "下列哪一個病例較符合所列 ABG 與血清電解質：pH 7.32、PaO2 110 mmHg、PaCO2 33 mmHg、HCO3− 18；Na+ 138、K+ 3.0、Cl− 109（mmol/L）？",
  "options": [
    { "key": "A", "text": "19 歲女學生第一型糖尿病，熬夜兩天忘記打胰島素" },
    { "key": "B", "text": "39 歲女性服用作用於遠端腎小管之利尿劑減重" },
    { "key": "C", "text": "59 歲女性第五期慢性腎臟病" },
    { "key": "D", "text": "69 歲女性腹瀉三天" }
  ],
  "answer": "D",
  "explanation": "此為代謝性酸中毒（HCO3− 下降），且 anion gap：138−109−18=11，屬 **non–anion gap metabolic acidosis**，最典型為腹瀉或 RTA。DKA/晚期 CKD 常見高 anion gap；部分利尿劑（如 loop/thiazide）多導致代謝性鹼中毒。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "血陰離子隙（blood anion gap）主要反應下列何項離子的多寡？",
  "options": [
    { "key": "A", "text": "未測量之陽離子（unmeasured cations）" },
    { "key": "B", "text": "鈉離子＋鉀離子（Na+ + K+）" },
    { "key": "C", "text": "未測量之陰離子（unmeasured anions）" },
    { "key": "D", "text": "重碳酸離子＋氯離子（HCO3− + Cl−）" }
  ],
  "answer": "C",
  "explanation": "Anion gap 可理解為「未測量陰離子相對增加」的指標：AG ≈（Na+）−（Cl− + HCO3−）（是否含 K+ 依公式而定）。乳酸、酮酸、尿毒素相關酸根等增加會使 AG 上升。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "下列哪一個病例最不符合所列 ABG 與電解質：pH 7.49、PaO2 90 mmHg、PaCO2 43 mmHg、HCO3− 28；Na+ 139、K+ 3.0、Cl− 89（mmol/L）？",
  "options": [
    { "key": "A", "text": "長期使用利尿劑" },
    { "key": "B", "text": "急性腹瀉三天" },
    { "key": "C", "text": "原發性醛固酮增多症" },
    { "key": "D", "text": "噁心嘔吐兩天" }
  ],
  "answer": "B",
  "explanation": "此組數據為代謝性鹼中毒（HCO3−↑、pH↑，PaCO2 代償上升），且低氯、低鉀常見於嘔吐、利尿劑或醛固酮過多。腹瀉典型為 **non–anion gap 代謝性酸中毒**（HCO3− 下降、Cl− 上升），最不符合。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "某病人 ABG：pH 7.51、PaCO2 49 mmHg、HCO3− 38 mmol/L。下列何者正確？",
  "options": [
    { "key": "A", "text": "代謝性酸中毒（酸血症）" },
    { "key": "B", "text": "代謝性鹼中毒" },
    { "key": "C", "text": "呼吸性酸中毒" },
    { "key": "D", "text": "呼吸性鹼中毒" }
  ],
  "answer": "B",
  "explanation": "pH 偏鹼且 HCO3− 顯著上升為主因，PaCO2 上升為呼吸代償，符合代謝性鹼中毒。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "下列哪一個病例不符合：pH 7.49、PaO2 90 mmHg、PaCO2 43 mmHg、HCO3− 28；Na+ 139、K+ 3.0、Cl− 89（mmol/L）？",
  "options": [
    { "key": "A", "text": "甲：40 歲女，半年高血壓，偶下肢無力；血漿醛固酮 38 ng/dL（正常 10–25）" },
    { "key": "B", "text": "乙：37 歲女，Sjogren's syndrome；腎臟超音波見兩側腎盂鈣化跡象" },
    { "key": "C", "text": "丙：30 歲男，急性胰臟炎住院，鼻胃管引流每天約 3,000 mL" },
    { "key": "D", "text": "丁：22 歲女長期服用 thiazide diuretics 減肥" }
  ],
  "answer": "B",
  "explanation": "此數據符合代謝性鹼中毒。甲（原發性醛固酮增多）可致代謝性鹼中毒；丙（大量胃液/NG suction）可致氯缺乏型代謝性鹼中毒；丁（thiazide）亦可致代謝性鹼中毒。Sjogren's 常與遠端 RTA（type 1）相關，典型為代謝性酸中毒，故最不符合。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "承上題，若檢查該病人尿液發現 Cl− 濃度為 10 mmol/L。何者最符合此結果？",
  "options": [
    { "key": "A", "text": "甲病人" },
    { "key": "B", "text": "乙病人" },
    { "key": "C", "text": "丙病人" },
    { "key": "D", "text": "丁病人" }
  ],
  "answer": "C",
  "explanation": "尿氯 <20 mmol/L 通常支持「saline responsive」的氯缺乏/低容積相關代謝性鹼中毒（如嘔吐或鼻胃管引流），最符合丙。長期利尿劑使用時尿氯往往 >20。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABAL_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡｜臨床實力演練" },
  "stem": "下列何者不是高陰離子間隙代謝性酸中毒（high anion gap metabolic acidosis）的原因？",
  "options": [
    { "key": "A", "text": "Lactic acidosis" },
    { "key": "B", "text": "Ketoacidosis" },
    { "key": "C", "text": "Diarrhea" },
    { "key": "D", "text": "Salicylate intoxication" }
  ],
  "answer": "C",
  "explanation": "腹瀉典型造成 **non–anion gap** 代謝性酸中毒（HCO3− 流失、Cl− 上升）。高 AG 代謝性酸中毒常見類別可記 lactate、ketone、toxin/drug、renal failure（尿毒）。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
  "stem": "下列哪一項最符合低血鈉（hyponatremia）之分型評估的第一步？",
  "options": [
    { "key": "A", "text": "直接給 3% 高張食鹽水" },
    { "key": "B", "text": "先判斷血清滲透壓（serum osmolality）屬於低/等/高張" },
    { "key": "C", "text": "先測尿鈉即可，不需其他資訊" },
    { "key": "D", "text": "先測甲狀腺功能即可確診" }
  ],
  "answer": "B",
  "explanation": "低血鈉評估的起點是先分辨是否為「低滲/等滲/高滲」情境；再結合病人容積狀態與尿滲透壓/尿鈉等，判斷 SIADH、低容積、心肝腎衰等原因。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
  "stem": "下列何者最符合 SIADH 的典型實驗室特徵？",
  "options": [
    { "key": "A", "text": "血清低滲、尿滲透壓偏低（稀尿）" },
    { "key": "B", "text": "血清低滲、尿滲透壓偏高（非適當濃縮）且尿鈉常不低" },
    { "key": "C", "text": "血清高滲、尿滲透壓偏低" },
    { "key": "D", "text": "血清等滲、尿滲透壓偏高必然為 SIADH" }
  ],
  "answer": "B",
  "explanation": "SIADH 為不適當 ADH 分泌，造成低滲性低血鈉，但尿液相對濃縮（Uosm 偏高），且在無低容積刺激下尿鈉常不低（>30 mEq/L 常見）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
  "stem": "嚴重症狀性低血鈉（如癲癇、昏迷）之急性處置原則，下列何者最恰當？",
  "options": [
    { "key": "A", "text": "限制飲水即可，避免任何輸液" },
    { "key": "B", "text": "立即給予 3% 高張食鹽水以先改善神經症狀" },
    { "key": "C", "text": "立即大量輸注 D5W 以避免鈉上升" },
    { "key": "D", "text": "先等尿電解質結果再決定" }
  ],
  "answer": "B",
  "explanation": "有神經學重症表現時，目標是先安全提升血鈉以解除腦水腫症狀（常以 3% NaCl 小量反覆 bolus 或依院內流程）；同時需避免過度矯正造成滲透性脫髓鞘。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜B 高血鈉" },
  "stem": "高血鈉（hypernatremia）最常見的病理機轉為何？",
  "options": [
    { "key": "A", "text": "鈉過量攝取" },
    { "key": "B", "text": "水分相對不足（自由水缺乏），多因失水或無法補水" },
    { "key": "C", "text": "腎臟排鈉過多" },
    { "key": "D", "text": "鉀離子過高導致鈉上升" }
  ],
  "answer": "B",
  "explanation": "高血鈉在臨床上多反映「自由水不足」而非鈉真的過量；常見於失水（腸胃道、皮膚、腎性如 DI）或無法取得水分的病人。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜B 高血鈉" },
  "stem": "懷疑尿崩症（diabetes insipidus, DI）造成高血鈉時，下列何者最符合典型尿液表現？",
  "options": [
    { "key": "A", "text": "尿量少且尿滲透壓高" },
    { "key": "B", "text": "多尿且尿滲透壓低（稀尿）" },
    { "key": "C", "text": "尿鈉一定很高" },
    { "key": "D", "text": "尿液一定有大量蛋白" }
  ],
  "answer": "B",
  "explanation": "DI 的核心為 ADH 缺乏或腎臟對 ADH 不反應，導致無法濃縮尿液→多尿、低尿滲透壓→自由水流失造成高血鈉。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
  "stem": "低血鉀（hypokalemia）最常見的原因類型為何？",
  "options": [
    { "key": "A", "text": "腎臟無法排酸" },
    { "key": "B", "text": "胃腸道或腎臟鉀流失（如嘔吐、腹瀉、利尿劑）" },
    { "key": "C", "text": "單純鈉攝取不足" },
    { "key": "D", "text": "血鈣過低" }
  ],
  "answer": "B",
  "explanation": "低血鉀常見於外流失（GI：腹瀉；腎：利尿劑、醛固酮作用↑等）或鉀移入細胞（胰島素、β-agonist、鹼中毒）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
  "stem": "高血壓合併低血鉀時，下列哪一項鑑別最典型需要優先考慮？",
  "options": [
    { "key": "A", "text": "SIADH" },
    { "key": "B", "text": "原發性醛固酮增多症（primary aldosteronism）" },
    { "key": "C", "text": "單純腸胃炎" },
    { "key": "D", "text": "腎絲球腎炎" }
  ],
  "answer": "B",
  "explanation": "高血壓 + 低血鉀是原發性醛固酮增多症的經典線索（也要想到利尿劑/腎血管性高血壓/甘草等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜D 高血鉀" },
  "stem": "下列何者為高血鉀（hyperkalemia）最常見的原因分類？",
  "options": [
    { "key": "A", "text": "腎排鉀能力下降（如 AKI/CKD 或 RAAS 抑制）" },
    { "key": "B", "text": "單純飲食攝取過多" },
    { "key": "C", "text": "維生素缺乏" },
    { "key": "D", "text": "血鈉過低必然造成高血鉀" }
  ],
  "answer": "A",
  "explanation": "臨床高血鉀多因腎臟排鉀能力下降或醛固酮作用不足/被抑制（AKI/CKD、ACEi/ARB、K-sparing diuretics、type 4 RTA 等），而非單純吃太多鉀。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜D 高血鉀" },
  "stem": "高血鉀病人出現心電圖變化時，最立即的處置目標為何？",
  "options": [
    { "key": "A", "text": "立即以樹脂把鉀排出體外" },
    { "key": "B", "text": "先穩定心肌細胞膜，降低致命心律不整風險" },
    { "key": "C", "text": "先補鈣以治療低血鈣" },
    { "key": "D", "text": "先給大量生理食鹽水以排鈉" }
  ],
  "answer": "B",
  "explanation": "高血鉀伴 ECG 改變時，第一優先是膜穩定（IV calcium gluconate/ chloride 依情境）以防心律不整；之後才是把鉀移入細胞與移出體外。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜E 鈣的平衡" },
  "stem": "下列何者最符合「低白蛋白血症造成總血鈣下降」的臨床意義？",
  "options": [
    { "key": "A", "text": "一定代表游離鈣（ionized Ca）也下降" },
    { "key": "B", "text": "可能是總鈣下降但游離鈣正常，需看 ionized Ca 或校正鈣" },
    { "key": "C", "text": "必然導致抽搐" },
    { "key": "D", "text": "與白蛋白無關" }
  ],
  "answer": "B",
  "explanation": "總鈣受白蛋白結合影響；低白蛋白會讓 total Ca 看起來偏低，但 ionized Ca 可能正常，因此需看 ionized Ca 或做校正（臨床上常用 correction 公式作概略判讀）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜F 磷的平衡" },
  "stem": "慢性腎臟病（CKD）病人常見的磷代謝異常為何？",
  "options": [
    { "key": "A", "text": "低血磷" },
    { "key": "B", "text": "高血磷" },
    { "key": "C", "text": "血磷一定正常" },
    { "key": "D", "text": "血磷與腎功能無關" }
  ],
  "answer": "B",
  "explanation": "CKD 因腎排磷能力下降而易高血磷，進而導致低鈣與次發性副甲狀腺亢進（CKD-MBD）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ELEC_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜乙 離子平衡｜F 磷的平衡" },
  "stem": "下列何者最符合 CKD 造成次發性副甲狀腺亢進（secondary hyperparathyroidism）的機轉？",
  "options": [
    { "key": "A", "text": "腎排磷下降→高血磷與活性維生素 D 下降→低血鈣→PTH 上升" },
    { "key": "B", "text": "腎排鈉下降→低血鈉→PTH 上升" },
    { "key": "C", "text": "腎排鉀下降→高血鉀→PTH 上升" },
    { "key": "D", "text": "單純飲食鈣攝取過多→PTH 上升" }
  ],
  "answer": "A",
  "explanation": "CKD-MBD 核心：排磷下降造成高磷，腎 1α-hydroxylation 下降使活性 Vit D 降低，腸鈣吸收下降→低鈣刺激 PTH 上升，形成次發性副甲狀腺亢進。"
},

  {
  "id": "MED3_RENAL_INF_ORI_AKI_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "KDIGO 對急性腎損傷（AKI）的診斷標準之一，下列何者正確？",
  "options": [
    { "key": "A", "text": "血清肌酸酐上升 ≥0.3 mg/dL 於 48 小時內" },
    { "key": "B", "text": "血清肌酸酐上升 ≥0.3 mg/dL 於 3 個月內" },
    { "key": "C", "text": "eGFR 只要低於 60 即為 AKI" },
    { "key": "D", "text": "只有尿量下降才算 AKI" }
  ],
  "answer": "A",
  "explanation": "KDIGO：Scr 48 小時內上升 ≥0.3 mg/dL，或 7 天內上升至基線 ≥1.5 倍，或尿量 <0.5 mL/kg/h 持續 ≥6 小時，皆可診斷 AKI。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合腎前性（prerenal）AKI 的典型尿液指標？",
  "options": [
    { "key": "A", "text": "尿鈉高、FENa >2%" },
    { "key": "B", "text": "尿鈉低、FENa <1%（無利尿劑影響時）" },
    { "key": "C", "text": "尿中大量 RBC casts" },
    { "key": "D", "text": "尿沈渣多為泥沙樣圓柱" }
  ],
  "answer": "B",
  "explanation": "腎前性 AKI 因有效循環血量不足，腎小管仍能保留鈉水：尿鈉低、FENa <1%、尿滲透壓較高。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "腎前性 AKI 與 ATN 的鑑別，BUN/Cr 比值常見差異為何？",
  "options": [
    { "key": "A", "text": "腎前性通常 <10；ATN 通常 >20" },
    { "key": "B", "text": "腎前性通常 >20；ATN 常較接近 10–15" },
    { "key": "C", "text": "兩者沒有任何差異" },
    { "key": "D", "text": "ATN 一定 >30" }
  ],
  "answer": "B",
  "explanation": "腎前性低灌流時腎小管重吸收尿素增加→BUN/Cr 比值偏高（>20 常被引用）；ATN 因小管損傷，重吸收能力下降→比值多較低/接近正常。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "使用利尿劑的病人懷疑腎前性 AKI 時，哪一個指標較能輔助鑑別（相較 FENa 較不受影響）？",
  "options": [
    { "key": "A", "text": "FEUrea（尿素分率排泄率）" },
    { "key": "B", "text": "血紅素" },
    { "key": "C", "text": "血小板" },
    { "key": "D", "text": "血清白蛋白" }
  ],
  "answer": "A",
  "explanation": "利尿劑會提高尿鈉、影響 FENa 判讀；FEUrea 在利尿劑情境下相對較可用。腎前性常見 FEUrea 偏低（常用門檻約 <35%）。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合腎後性（postrenal）AKI 的臨床處置優先？",
  "options": [
    { "key": "A", "text": "立即給予高劑量利尿劑以排尿" },
    { "key": "B", "text": "先排除/解除尿路阻塞（如導尿、腎造口/輸尿管支架）" },
    { "key": "C", "text": "先給類固醇" },
    { "key": "D", "text": "先做腎穿刺活檢" }
  ],
  "answer": "B",
  "explanation": "腎後性 AKI 的核心是阻塞：優先確認並解除（導尿、泌尿科處置）。延誤解除可能造成不可逆腎損傷。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "腎後性阻塞造成的 AKI，超音波最常見的影像線索為何？",
  "options": [
    { "key": "A", "text": "腎皮質變薄" },
    { "key": "B", "text": "腎盂腎盞擴張（hydronephrosis）" },
    { "key": "C", "text": "腎臟鈣化一定存在" },
    { "key": "D", "text": "雙腎一定縮小" }
  ],
  "answer": "B",
  "explanation": "阻塞常見 hydronephrosis；但早期或特定情境（如後腹膜纖維化、嚴重脫水）也可能不典型，因此仍需臨床整合。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "急性間質性腎炎（AIN）最典型的誘因為何？",
  "options": [
    { "key": "A", "text": "藥物（如 β-lactam、PPI、NSAIDs 等）" },
    { "key": "B", "text": "單純飲水不足" },
    { "key": "C", "text": "高蛋白飲食" },
    { "key": "D", "text": "運動過量" }
  ],
  "answer": "A",
  "explanation": "AIN 最常見為藥物誘發的過敏/免疫反應；也可見感染或自體免疫相關，但考題常以藥物為主。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "關於急性間質性腎炎（AIN）的典型臨床/尿液表現，下列何者最符合？",
  "options": [
    { "key": "A", "text": "泥沙樣圓柱為主" },
    { "key": "B", "text": "無菌性膿尿、嗜酸性球尿（eosinophiluria）可見" },
    { "key": "C", "text": "一定大量蛋白尿 >3.5 g/day" },
    { "key": "D", "text": "尿鈉一定 <10" }
  ],
  "answer": "B",
  "explanation": "AIN 常見無菌性膿尿、WBC casts，部分可見 eosinophiluria；臨床三聯徵（發燒、皮疹、嗜酸性球增多）不一定齊全。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0013",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合 ATN（acute tubular necrosis）的典型尿沈渣？",
  "options": [
    { "key": "A", "text": "RBC casts" },
    { "key": "B", "text": "WBC casts" },
    { "key": "C", "text": "muddy brown granular casts" },
    { "key": "D", "text": "大量卵圓脂肪體（oval fat bodies）" }
  ],
  "answer": "C",
  "explanation": "ATN 尿沈渣典型為 granular casts（muddy brown）；RBC casts 偏向腎小球性血尿，WBC casts 偏向腎盂腎炎或 AIN；oval fat bodies 偏向腎病症候群。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0014",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "哪一種情境最可能造成缺血型 ATN？",
  "options": [
    { "key": "A", "text": "短暫輕度脫水且迅速補液" },
    { "key": "B", "text": "長時間低血壓/休克（如敗血症、重大手術出血）" },
    { "key": "C", "text": "單純發燒" },
    { "key": "D", "text": "高血壓未控制" }
  ],
  "answer": "B",
  "explanation": "缺血型 ATN 常由持續低灌流/休克造成；若腎前性低灌流未及時矯正可進展為 ATN。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0015",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列哪一項藥物最典型與腎毒性（nephrotoxicity）相關，可造成 AKI？",
  "options": [
    { "key": "A", "text": "Aminoglycoside" },
    { "key": "B", "text": "Macrolide" },
    { "key": "C", "text": "Penicillin V 口服低劑量" },
    { "key": "D", "text": "Metronidazole" }
  ],
  "answer": "A",
  "explanation": "Aminoglycoside 可造成近端小管毒性導致 ATN；其他仍可能有副作用，但考題中 aminoglycoside 是經典腎毒性代表。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0016",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "造影劑相關急性腎損傷（contrast-associated AKI）之預防，下列何者最恰當？",
  "options": [
    { "key": "A", "text": "檢查後立即給予 NSAIDs 以止痛" },
    { "key": "B", "text": "適當補液（isotonic fluid）並避免不必要腎毒性藥物" },
    { "key": "C", "text": "只要使用高滲葡萄糖液即可預防" },
    { "key": "D", "text": "不需評估風險，所有人風險相同" }
  ],
  "answer": "B",
  "explanation": "預防核心是風險評估、適當輸液（常用等張液）、避免/暫停腎毒性藥物、使用必要且最低量造影劑。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0017",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合「腎前性 AKI 若不矯正可進展為 ATN」的臨床意義？",
  "options": [
    { "key": "A", "text": "腎前性與 ATN 完全無關" },
    { "key": "B", "text": "持續低灌流會造成小管缺血損傷，從功能性變成結構性損傷" },
    { "key": "C", "text": "只要有蛋白尿就一定是 ATN" },
    { "key": "D", "text": "ATN 一定會在 24 小時內完全恢復" }
  ],
  "answer": "B",
  "explanation": "腎前性為功能性低灌流；若低灌流持續或嚴重，會導致小管細胞缺血壞死→ATN（結構性損傷），此為臨床上「及早補液/改善灌流」的重要理由。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0018",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合 AKI 初步評估的檢查策略？",
  "options": [
    { "key": "A", "text": "所有人一律先做腎穿刺活檢" },
    { "key": "B", "text": "先確認尿量與生命徵象，檢視用藥與體液狀態，並做尿液分析與腎超音波排除阻塞" },
    { "key": "C", "text": "只要抽一次肌酸酐即可，不需追蹤" },
    { "key": "D", "text": "先給利尿劑，若有尿就代表腎功能正常" }
  ],
  "answer": "B",
  "explanation": "AKI 初步要先分三大類：prerenal/intrinsic/postrenal。臨床上會先看尿量、循環狀態與藥物史，做 UA/尿沈渣、電解質指標，並以腎超音波排除阻塞。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0019",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "AKI 病人出現下列哪一項情況時，最需要立即處理以避免致命併發症？",
  "options": [
    { "key": "A", "text": "輕度蛋白尿" },
    { "key": "B", "text": "高血鉀合併心電圖變化" },
    { "key": "C", "text": "血尿顯微鏡下 1–2/HPF" },
    { "key": "D", "text": "尿比重偏高" }
  ],
  "answer": "B",
  "explanation": "AKI 的立即危險處置常圍繞 AEIOU，尤其高血鉀合併 ECG 變化屬高風險，需立刻進行膜穩定與降鉀處置。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0020",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "AKI 病人若出現急性肺水腫且利尿劑無效，最恰當的下一步為何？",
  "options": [
    { "key": "A", "text": "繼續加倍口服利尿劑並觀察" },
    { "key": "B", "text": "考慮腎臟替代治療（透析/超濾）以控制液體" },
    { "key": "C", "text": "停止所有輸液但不需其他處置" },
    { "key": "D", "text": "僅給鎮靜藥即可" }
  ],
  "answer": "B",
  "explanation": "難以控制的肺水腫/容量過負荷是透析（腎臟替代治療）常見適應症之一；若利尿劑無效且呼吸循環受影響，應及早升級處置。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0021",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "下列何者最符合「腎功能指標」在 AKI 的解讀限制？",
  "options": [
    { "key": "A", "text": "血清肌酸酐會即時反映 GFR 的變化" },
    { "key": "B", "text": "血清肌酸酐在急性變化時有滯後性，早期可能低估嚴重度" },
    { "key": "C", "text": "尿量與 AKI 毫無關聯" },
    { "key": "D", "text": "只要肌酸酐正常即可排除 AKI" }
  ],
  "answer": "B",
  "explanation": "Scr 上升需時間累積，急性期可能尚未顯著上升而低估 AKI；因此臨床需結合尿量、趨勢、風險與其他線索。"
},
{
  "id": "MED3_RENAL_INF_ORI_AKI_Q0022",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
  "stem": "哪一種尿沈渣線索最支持「腎小球性」病變造成 AKI？",
  "options": [
    { "key": "A", "text": "RBC casts" },
    { "key": "B", "text": "muddy brown casts" },
    { "key": "C", "text": "大量結晶" },
    { "key": "D", "text": "透明圓柱（hyaline casts）" }
  ],
  "answer": "A",
  "explanation": "RBC casts 強烈提示腎小球出血/腎炎相關；ATN 偏向 granular casts；hyaline casts 可見於脫水/運動等非特異狀態。"
},

  {
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "下列何者最能支持「腎小球性血尿」而非下泌尿道出血？",
  "options": [
    { "key": "A", "text": "尿液呈鮮紅色且無蛋白尿" },
    { "key": "B", "text": "尿沈渣可見 RBC casts 或 dysmorphic RBC" },
    { "key": "C", "text": "尿液培養陽性" },
    { "key": "D", "text": "排尿疼痛明顯" }
  ],
  "answer": "B",
  "explanation": "RBC casts／變形紅血球（dysmorphic RBC）高度提示腎小球來源的血尿，常見於腎炎相關病變。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "腎病症候群（nephrotic syndrome）的主要併發症，下列何者最典型？",
  "options": [
    { "key": "A", "text": "出血傾向" },
    { "key": "B", "text": "血栓栓塞風險上升（hypercoagulability）" },
    { "key": "C", "text": "持續性低血壓" },
    { "key": "D", "text": "高血糖必然發生" }
  ],
  "answer": "B",
  "explanation": "nephrotic syndrome 因蛋白流失（含抗凝蛋白）與肝臟代償合成等，導致高凝狀態，增加 DVT/PE、腎靜脈栓塞風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "小兒腎病症候群最常見病因（minimal change disease）在腎臟電子顯微鏡（EM）最典型的發現為何？",
  "options": [
    { "key": "A", "text": "subepithelial hump" },
    { "key": "B", "text": "podocyte foot process effacement" },
    { "key": "C", "text": "tram-track appearance" },
    { "key": "D", "text": "Crescent formation" }
  ],
  "answer": "B",
  "explanation": "minimal change disease LM 多正常、IF 陰性，EM 典型為足突融合（foot process effacement）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "成人 nephrotic syndrome 若合併高凝狀態特別明顯（如腎靜脈栓塞），最典型相關病變為何？",
  "options": [
    { "key": "A", "text": "Minimal change disease" },
    { "key": "B", "text": "Membranous nephropathy" },
    { "key": "C", "text": "IgA nephropathy" },
    { "key": "D", "text": "Acute poststreptococcal GN" }
  ],
  "answer": "B",
  "explanation": "membranous nephropathy 與血栓栓塞（尤其腎靜脈栓塞）風險增加是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "Membranous nephropathy 最典型的免疫螢光（IF）/超微結構特徵為何？",
  "options": [
    { "key": "A", "text": "線性（linear）IgG 沿 GBM" },
    { "key": "B", "text": "顆粒狀（granular）沉積，subepithelial deposits（spike and dome）" },
    { "key": "C", "text": "只有 C3 沉積，無免疫球蛋白" },
    { "key": "D", "text": "mesangial IgA 為主" }
  ],
  "answer": "B",
  "explanation": "membranous nephropathy 經典為 granular IF，EM 見 subepithelial immune deposits，LM 可見 spike。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "關於 FSGS（focal segmental glomerulosclerosis），下列何者正確？",
  "options": [
    { "key": "A", "text": "最常見於兒童且對類固醇反應極佳" },
    { "key": "B", "text": "可與 HIV、heroin、肥胖或減少腎元狀態相關" },
    { "key": "C", "text": "典型為 subepithelial hump" },
    { "key": "D", "text": "不會進展至末期腎病" }
  ],
  "answer": "B",
  "explanation": "FSGS 可為原發或繼發（HIV、肥胖、腎元減少等），治療反應較不佳，部分會進展至 CKD/ESRD。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "急性鏈球菌感染後腎炎（PSGN）最典型的補體變化為何？",
  "options": [
    { "key": "A", "text": "C3 下降，C4 多正常" },
    { "key": "B", "text": "C3 與 C4 都上升" },
    { "key": "C", "text": "只有 C4 下降" },
    { "key": "D", "text": "補體一定正常" }
  ],
  "answer": "A",
  "explanation": "PSGN 常見低補體（尤其 C3）且多在數週內回復；常用於鑑別 IgA（補體多正常）等。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "PSGN 的超微結構（EM）典型沉積型態為何？",
  "options": [
    { "key": "A", "text": "subepithelial humps" },
    { "key": "B", "text": "subendothelial deposits" },
    { "key": "C", "text": "線性沉積於 GBM" },
    { "key": "D", "text": "只在 mesangium 沉積 IgA" }
  ],
  "answer": "A",
  "explanation": "PSGN 經典為 subepithelial humps（免疫複合體沉積）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "IgA 腎病變的典型免疫螢光（IF）沉積位置為何？",
  "options": [
    { "key": "A", "text": "GBM 線性 IgG" },
    { "key": "B", "text": "mesangial IgA 沉積" },
    { "key": "C", "text": "只沉積 C1q" },
    { "key": "D", "text": "subepithelial spike" }
  ],
  "answer": "B",
  "explanation": "IgA nephropathy 典型為 mesangial IgA 沉積。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "上呼吸道感染後 1–2 天內出現肉眼血尿，下列何者最符合？",
  "options": [
    { "key": "A", "text": "PSGN" },
    { "key": "B", "text": "IgA nephropathy" },
    { "key": "C", "text": "Minimal change disease" },
    { "key": "D", "text": "Alport syndrome 必然" }
  ],
  "answer": "B",
  "explanation": "IgA 常為「synpharyngitic hematuria」：感染後很短時間內出現血尿；PSGN 多為感染後 1–3 週。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "快速進行性腎絲球腎炎（RPGN）在腎臟病理最典型的共同特徵為何？",
  "options": [
    { "key": "A", "text": "Crescent formation" },
    { "key": "B", "text": "podocyte foot process effacement" },
    { "key": "C", "text": "spike and dome" },
    { "key": "D", "text": "subepithelial humps 一定存在" }
  ],
  "answer": "A",
  "explanation": "RPGN 的病理共同表現為腎小球新月體（crescent），代表嚴重腎小球損傷與快速腎功能惡化。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "Goodpasture（anti-GBM disease）的典型免疫螢光表現為何？",
  "options": [
    { "key": "A", "text": "granular IgG 沿 GBM" },
    { "key": "B", "text": "linear IgG 沿 GBM" },
    { "key": "C", "text": "mesangial IgA 沉積" },
    { "key": "D", "text": "只有 C3 沉積" }
  ],
  "answer": "B",
  "explanation": "anti-GBM disease 經典為線性（linear）IgG 沿 GBM；臨床可見肺腎症候群（咳血 + RPGN）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0013",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "ANCA 相關血管炎造成的 RPGN（pauci-immune GN）最符合下列何者？",
  "options": [
    { "key": "A", "text": "免疫螢光常呈現「pauci-immune」（沉積少或陰性）" },
    { "key": "B", "text": "一定有大量 IgA 沉積" },
    { "key": "C", "text": "一定伴隨 C3 顯著下降" },
    { "key": "D", "text": "一定會有 subepithelial humps" }
  ],
  "answer": "A",
  "explanation": "ANCA 相關 RPGN 常為 pauci-immune（IF 幾乎陰性或沉積少），與 immune complex 或 anti-GBM 型不同。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0014",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "下列哪一項最符合膜增生性腎絲球腎炎（MPGN）/免疫複合體型腎炎常見的臨床線索？",
  "options": [
    { "key": "A", "text": "低補體（尤其 C3）可見" },
    { "key": "B", "text": "補體一定正常" },
    { "key": "C", "text": "只會表現為單純高血鈉" },
    { "key": "D", "text": "一定伴隨明顯嗜酸性球尿" }
  ],
  "answer": "A",
  "explanation": "MPGN/免疫複合體相關腎炎常伴補體消耗（C3 下降）並可能與感染（如 HCV）或免疫疾病相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0015",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "系統性紅斑性狼瘡（SLE）腎炎常見的免疫螢光特徵（考題常用）為何？",
  "options": [
    { "key": "A", "text": "線性 IgG 單一沉積" },
    { "key": "B", "text": "“full house” 沉積（IgG/IgA/IgM/C3/C1q）" },
    { "key": "C", "text": "只有 IgA 沉積" },
    { "key": "D", "text": "完全無沉積（pauci-immune）" }
  ],
  "answer": "B",
  "explanation": "lupus nephritis 常見 “full house” IF（多種免疫球蛋白與補體同時沉積）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0016",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "下列何者最符合「腎病症候群」與「腎炎症候群」的差異重點？",
  "options": [
    { "key": "A", "text": "nephrotic 以大量蛋白尿/低白蛋白/水腫/高血脂為主；nephritic 以血尿、RBC casts、高血壓與腎功能下降為主" },
    { "key": "B", "text": "兩者臨床完全無法區分" },
    { "key": "C", "text": "nephritic 一定無血尿" },
    { "key": "D", "text": "nephrotic 一定無任何併發症" }
  ],
  "answer": "A",
  "explanation": "這是兩大腎小球症候群的核心鑑別：nephrotic（蛋白/水腫/脂質/凝血）vs nephritic（血尿/高血壓/腎功能）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0017",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "Hepatitis B 與 membranous nephropathy 的關聯、以及 Hepatitis C 與 MPGN 的關聯，何者正確？",
  "options": [
    { "key": "A", "text": "HBV 與 MPGN；HCV 與 minimal change" },
    { "key": "B", "text": "HBV 與 membranous；HCV 與 MPGN（特別是混合型冷凝球蛋白血症相關）" },
    { "key": "C", "text": "HBV 只會導致腎結石" },
    { "key": "D", "text": "HCV 與腎臟病無關" }
  ],
  "answer": "B",
  "explanation": "經典關聯：HBV 可與 membranous nephropathy；HCV 常與 MPGN/冷凝球蛋白血症相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0018",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "成人 nephrotic syndrome 初步評估中，下列何者最常用來支持「糖尿病腎病變」的臨床線索？",
  "options": [
    { "key": "A", "text": "突然出現大量血尿且 RBC casts" },
    { "key": "B", "text": "長期糖尿病病史合併視網膜病變（diabetic retinopathy）" },
    { "key": "C", "text": "急性上呼吸道感染後 1–2 天血尿" },
    { "key": "D", "text": "短期使用 PPI 後發燒皮疹" }
  ],
  "answer": "B",
  "explanation": "臨床上糖尿病腎病變常與長病程、微血管病變（如視網膜病變）並存；若臨床不典型才更需要考慮其他腎小球病變與腎切片。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0019",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "腎小球疾病中，若看到「線性」免疫沉積，最優先聯想到的病理機轉為何？",
  "options": [
    { "key": "A", "text": "免疫複合體沉積（immune complex）" },
    { "key": "B", "text": "抗 GBM 抗體直接結合（anti-GBM）" },
    { "key": "C", "text": "pauci-immune ANCA 相關" },
    { "key": "D", "text": "只會是 IgA" }
  ],
  "answer": "B",
  "explanation": "線性（linear）沉積典型對應 anti-GBM disease；免疫複合體多為顆粒狀（granular），ANCA 多為 pauci-immune。"
},
{
  "id": "MED3_RENAL_INF_ORI_GLOM_Q0020",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜A 腎絲球疾病（Glomerular disease）" },
  "stem": "下列何者最符合「何時需要考慮腎切片（renal biopsy）」的原則概念？",
  "options": [
    { "key": "A", "text": "只要有任何輕度蛋白尿就一定要切片" },
    { "key": "B", "text": "原因不明的顯著蛋白尿/血尿合併腎功能惡化、或疑 RPGN 時常需切片以決定治療" },
    { "key": "C", "text": "只要超音波正常就不需切片" },
    { "key": "D", "text": "腎切片只能用在腎結石" }
  ],
  "answer": "B",
  "explanation": "腎切片常用於釐清腎小球病變類型、評估活動度/慢性度並指引免疫治療；尤其不明原因的重度蛋白尿、腎炎表現、快速惡化者。"
},

  {
  "id": "MED3_RENAL_INF_ORI_TUB_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "關於近端腎小管功能失常（Fanconi syndrome），下列何者最符合？",
  "options": [
    { "key": "A", "text": "只會造成單純高血鈉" },
    { "key": "B", "text": "可見葡萄糖尿（非糖尿病）、磷尿、胺基酸尿與近端 RTA" },
    { "key": "C", "text": "必然造成高血鉀" },
    { "key": "D", "text": "尿沈渣以 RBC casts 為主" }
  ],
  "answer": "B",
  "explanation": "Fanconi 為近端小管廣泛再吸收障礙，典型為 normoglycemic glucosuria、phosphaturia、aminoaciduria、bicarbonaturia（近端 RTA）。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "近端腎小管性酸中毒（type 2 RTA）最典型的酸鹼/電解質組合為何？",
  "options": [
    { "key": "A", "text": "高血鉀 + 高陰離子間隙代謝性酸中毒" },
    { "key": "B", "text": "低血鉀 + 高氯性（non–anion gap）代謝性酸中毒" },
    { "key": "C", "text": "高血鈉 + 代謝性鹼中毒" },
    { "key": "D", "text": "低血鈉 + 呼吸性酸中毒" }
  ],
  "answer": "B",
  "explanation": "type 2 RTA 為 HCO3− 再吸收障礙 → non–anion gap metabolic acidosis，常伴腎性鉀流失 → 低血鉀。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "遠端腎小管性酸中毒（type 1 RTA）的典型特色，下列何者正確？",
  "options": [
    { "key": "A", "text": "尿 pH 常能降到 <5.5" },
    { "key": "B", "text": "容易形成腎結石（calcium phosphate stones）" },
    { "key": "C", "text": "一定高血鉀" },
    { "key": "D", "text": "僅見於糖尿病患者" }
  ],
  "answer": "B",
  "explanation": "type 1 RTA 為遠端排酸障礙，尿液無法酸化（尿 pH 常 >5.5），常見低血鉀、腎鈣化/腎結石風險上升。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "下列何者最符合低腎素低醛固酮血症（type 4 RTA）的典型表現？",
  "options": [
    { "key": "A", "text": "低血鉀 + 代謝性鹼中毒" },
    { "key": "B", "text": "高血鉀 + 高氯性（non–anion gap）代謝性酸中毒" },
    { "key": "C", "text": "高陰離子間隙代謝性酸中毒" },
    { "key": "D", "text": "高血鈣 + 代謝性鹼中毒" }
  ],
  "answer": "B",
  "explanation": "type 4 RTA（低醛固酮或抗醛固酮狀態）→ 排鉀/排酸能力下降：高血鉀 + non–anion gap metabolic acidosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Bartter syndrome 與 Gitelman syndrome 的共同點，下列何者最正確？",
  "options": [
    { "key": "A", "text": "都會造成代謝性酸中毒" },
    { "key": "B", "text": "都可能造成低血鉀與代謝性鹼中毒" },
    { "key": "C", "text": "都會造成高血壓" },
    { "key": "D", "text": "都會造成高血鉀" }
  ],
  "answer": "B",
  "explanation": "兩者皆屬鹽流失性小管病變，常見低血鉀與代謝性鹼中毒；血壓多正常或偏低。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Gitelman syndrome 最典型的鑑別線索之一為何？",
  "options": [
    { "key": "A", "text": "高血鈣尿（hypercalciuria）" },
    { "key": "B", "text": "低血鎂（hypomagnesemia）與低尿鈣（hypocalciuria）" },
    { "key": "C", "text": "高血鉀" },
    { "key": "D", "text": "嚴重蛋白尿" }
  ],
  "answer": "B",
  "explanation": "Gitelman（類 thiazide）典型：低血鉀代謝性鹼中毒 + 低鎂 + 低尿鈣；Bartter（類 loop）較常高尿鈣。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Bartter syndrome 最典型的鑑別線索之一為何？",
  "options": [
    { "key": "A", "text": "低尿鈣（hypocalciuria）" },
    { "key": "B", "text": "高尿鈣（hypercalciuria）" },
    { "key": "C", "text": "高血鉀" },
    { "key": "D", "text": "高血壓" }
  ],
  "answer": "B",
  "explanation": "Bartter（類 loop）常見高尿鈣；Gitelman（類 thiazide）常見低尿鈣與低鎂。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Liddle syndrome 的典型組合為何？",
  "options": [
    { "key": "A", "text": "低血壓 + 高血鉀 + 代謝性酸中毒" },
    { "key": "B", "text": "高血壓 + 低血鉀 + 代謝性鹼中毒，且 renin/aldosterone 低" },
    { "key": "C", "text": "高血壓 + 高血鉀 + 代謝性酸中毒" },
    { "key": "D", "text": "正常血壓 + 高血鈉" }
  ],
  "answer": "B",
  "explanation": "Liddle 為 ENaC 過度活化→鈉水滯留：高血壓、低血鉀代謝性鹼中毒；因容量擴張使 renin 與 aldosterone 都低。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Gordon syndrome（pseudohypoaldosteronism type 2）最典型的電解質/酸鹼表現為何？",
  "options": [
    { "key": "A", "text": "高血壓 + 高血鉀 + 高氯性代謝性酸中毒" },
    { "key": "B", "text": "高血壓 + 低血鉀 + 代謝性鹼中毒" },
    { "key": "C", "text": "低血壓 + 低血鉀 + 代謝性鹼中毒" },
    { "key": "D", "text": "低血壓 + 高血鉀 + 高陰離子間隙酸中毒" }
  ],
  "answer": "A",
  "explanation": "Gordon（WNK 相關）常見高血壓合併高血鉀與高氯性代謝性酸中毒，與醛固酮過多（低鉀鹼中毒）相反。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "慢性間質性腎炎（chronic tubulointerstitial nephritis）最典型的尿液表現為何？",
  "options": [
    { "key": "A", "text": "大量蛋白尿（>3.5 g/day）" },
    { "key": "B", "text": "尿濃縮能力下降（低比重尿）、多尿/夜尿，蛋白尿多為輕中度" },
    { "key": "C", "text": "RBC casts 為主" },
    { "key": "D", "text": "尿沈渣完全正常且無任何線索" }
  ],
  "answer": "B",
  "explanation": "間質/小管疾病常見濃縮功能受損→多尿、夜尿、低比重尿；蛋白尿通常不如腎小球疾病那麼大量。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "止痛藥相關腎病變（analgesic nephropathy）最典型的病理/影像線索之一為何？",
  "options": [
    { "key": "A", "text": "腎乳頭壞死（papillary necrosis）" },
    { "key": "B", "text": "subepithelial humps" },
    { "key": "C", "text": "線性 IgG 沉積" },
    { "key": "D", "text": "大量 oval fat bodies" }
  ],
  "answer": "A",
  "explanation": "長期止痛藥（尤其 NSAIDs/合併製劑）可造成慢性間質腎炎與腎乳頭壞死，是常考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "下列何者最符合急性腎盂腎炎（acute pyelonephritis）之尿沈渣特徵？",
  "options": [
    { "key": "A", "text": "RBC casts" },
    { "key": "B", "text": "WBC casts" },
    { "key": "C", "text": "muddy brown casts" },
    { "key": "D", "text": "oval fat bodies" }
  ],
  "answer": "B",
  "explanation": "腎盂腎炎常見膿尿、WBC casts；RBC casts 偏向腎小球腎炎，muddy brown casts 偏向 ATN。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "急性間質性腎炎（AIN）的典型處置原則，下列何者最正確？",
  "options": [
    { "key": "A", "text": "不需停藥，持續觀察即可" },
    { "key": "B", "text": "先移除誘因（停可疑藥物），必要時視情況考慮類固醇" },
    { "key": "C", "text": "立即大量輸注高張食鹽水" },
    { "key": "D", "text": "一律需緊急透析" }
  ],
  "answer": "B",
  "explanation": "AIN 首要是停掉致病藥物/誘因並支持治療；嚴重或恢復不佳者可考慮類固醇（依臨床與病理評估）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GFRREG_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜D 腎絲球過濾率自主控制" },
  "stem": "腎絲球過濾率（GFR）自主調控中，入球小動脈（afferent arteriole）主要透過哪一機轉進行自我調節？",
  "options": [
    { "key": "A", "text": "心房利鈉胜肽（ANP）" },
    { "key": "B", "text": "肌源性反射（myogenic response）與致密斑回饋（tubuloglomerular feedback）" },
    { "key": "C", "text": "Erythropoietin 直接收縮" },
    { "key": "D", "text": "甲狀腺素直接舒張" }
  ],
  "answer": "B",
  "explanation": "腎自主調控的兩大核心：myogenic response 與 tubuloglomerular feedback（macula densa 感知 NaCl，調整入球張力與 renin）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GFRREG_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜D 腎絲球過濾率自主控制" },
  "stem": "在 RAAS 系統中，angiotensin II 對腎小球血流動力最典型的作用為何？",
  "options": [
    { "key": "A", "text": "主要擴張入球小動脈" },
    { "key": "B", "text": "主要收縮出球小動脈（efferent arteriole）以維持 GFR" },
    { "key": "C", "text": "只會降低血壓" },
    { "key": "D", "text": "與腎血流無關" }
  ],
  "answer": "B",
  "explanation": "Ang II 偏向收縮出球小動脈，使腎小球毛細血管壓上升，有助在低灌流時維持 GFR；也會降低腎血流量並影響濾過分率。"
},
{
  "id": "MED3_RENAL_INF_ORI_GFRREG_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜D 腎絲球過濾率自主控制" },
  "stem": "ACEi/ARB 可能導致 AKI 的典型情境為何？",
  "options": [
    { "key": "A", "text": "單側腎動脈狹窄且另一側腎正常" },
    { "key": "B", "text": "雙側腎動脈狹窄或單腎病人有腎動脈狹窄" },
    { "key": "C", "text": "健康年輕人短期使用" },
    { "key": "D", "text": "只要有高血壓就一定會 AKI" }
  ],
  "answer": "B",
  "explanation": "在腎灌流依賴 Ang II 維持出球收縮以維持 GFR 的狀態（雙側 RAS/單腎 RAS、嚴重低容積等），阻斷 RAAS 會使 GFR 下降而誘發 AKI。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "腎動脈狹窄（RAS）最常見的病因為何？",
  "options": [
    { "key": "A", "text": "腎小球腎炎" },
    { "key": "B", "text": "動脈粥樣硬化（atherosclerosis）" },
    { "key": "C", "text": "腎結石" },
    { "key": "D", "text": "腎腫瘤壓迫為最常見" }
  ],
  "answer": "B",
  "explanation": "RAS 最常見為粥樣硬化性狹窄（多見於年長、心血管危險因子族群）；另有 fibromuscular dysplasia（年輕女性較典型）。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "下列何者最符合 fibromuscular dysplasia（FMD）造成腎動脈狹窄的典型族群/線索？",
  "options": [
    { "key": "A", "text": "年輕女性、可呈現 \"string-of-beads\" 影像" },
    { "key": "B", "text": "年長男性、廣泛動脈粥樣硬化" },
    { "key": "C", "text": "只有糖尿病患者會發生" },
    { "key": "D", "text": "一定合併大量蛋白尿" }
  ],
  "answer": "A",
  "explanation": "FMD 多見於年輕女性，血管造影可見串珠樣（string-of-beads）；粥樣硬化型則多見於年長、有血管危險因子者。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "下列何者最符合腎動脈狹窄的臨床提示？",
  "options": [
    { "key": "A", "text": "突然出現難控制高血壓，且腹部可聽到血管雜音" },
    { "key": "B", "text": "反覆腸胃炎" },
    { "key": "C", "text": "單純皮疹與嗜酸性球增多" },
    { "key": "D", "text": "長期夜尿但血壓正常" }
  ],
  "answer": "A",
  "explanation": "RAS 常見線索：新發或惡化的難治高血壓、腹部雜音、腎功能在 ACEi/ARB 後惡化、反覆 flash pulmonary edema 等。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "腎動脈狹窄病人使用 ACEi/ARB 後腎功能惡化，最典型的血流動力學解釋為何？",
  "options": [
    { "key": "A", "text": "入球小動脈過度收縮" },
    { "key": "B", "text": "出球小動脈失去 Ang II 收縮→腎小球內壓下降→GFR 降低" },
    { "key": "C", "text": "腎小球基底膜被抗體破壞" },
    { "key": "D", "text": "腎小管直接被藥物毒性破壞為唯一原因" }
  ],
  "answer": "B",
  "explanation": "在 RAS 情境下腎灌流下降，腎臟依賴 Ang II 收縮出球以維持 GFR；ACEi/ARB 阻斷後出球舒張，腎小球內壓下降導致 GFR 下降。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "下列哪一種臨床情境最支持「腎動脈狹窄」需高度懷疑？",
  "options": [
    { "key": "A", "text": "反覆 flash pulmonary edema（突發性肺水腫）" },
    { "key": "B", "text": "單純偏頭痛" },
    { "key": "C", "text": "單純過敏性鼻炎" },
    { "key": "D", "text": "青春痘" }
  ],
  "answer": "A",
  "explanation": "反覆 flash pulmonary edema 是重要線索之一（尤其雙側 RAS 或單腎 RAS），與容量調控/RAAS 活化及心腎交互作用相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "下列何者最符合「尿液無法濃縮」的臨床表現？",
  "options": [
    { "key": "A", "text": "夜尿、多尿、尿比重低" },
    { "key": "B", "text": "少尿、尿比重高" },
    { "key": "C", "text": "血尿為主" },
    { "key": "D", "text": "大量蛋白尿為主" }
  ],
  "answer": "A",
  "explanation": "小管/間質疾病常先影響濃縮功能，出現多尿、夜尿與低比重尿。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "若病人出現 low-renin hypertension，且血鉀偏低、代謝性鹼中毒，最不符合下列哪一項？",
  "options": [
    { "key": "A", "text": "Liddle syndrome" },
    { "key": "B", "text": "服用甘草（licorice）造成 apparent mineralocorticoid excess" },
    { "key": "C", "text": "原發性醛固酮增多症" },
    { "key": "D", "text": "腎動脈狹窄" }
  ],
  "answer": "D",
  "explanation": "腎動脈狹窄屬 RAAS 活化 → 高 renin；其餘（Liddle、甘草/AME）多為低 renin、低 aldosterone；原發性醛固酮增多症為低 renin 但 aldosterone 高。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "腎乳頭壞死（papillary necrosis）可見於下列哪一組經典病因？",
  "options": [
    { "key": "A", "text": "糖尿病、鎌刀型貧血/trait、急性腎盂腎炎、長期止痛藥使用" },
    { "key": "B", "text": "甲亢、痛風、膽結石、肺炎" },
    { "key": "C", "text": "氣喘、異位性皮膚炎、過敏性鼻炎、蕁麻疹" },
    { "key": "D", "text": "僅見於 IgA 腎病變" }
  ],
  "answer": "A",
  "explanation": "papillary necrosis 常見經典組合可記：SAAD（Sickle cell, Acute pyelonephritis, Analgesics, Diabetes）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GFRREG_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜D 腎絲球過濾率自主控制" },
  "stem": "NSAIDs 可能造成腎前性 AKI 的血流動力學機轉，下列何者最符合？",
  "options": [
    { "key": "A", "text": "抑制前列腺素→入球小動脈收縮→GFR 下降" },
    { "key": "B", "text": "抑制 Ang II→出球小動脈舒張→GFR 上升" },
    { "key": "C", "text": "直接造成 anti-GBM disease" },
    { "key": "D", "text": "使腎血流必然上升" }
  ],
  "answer": "A",
  "explanation": "腎灌流受限時前列腺素有助入球擴張以維持 GFR；NSAIDs 抑制前列腺素使入球收縮，易誘發腎前性 AKI（尤其低容積/心衰/肝硬化等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_GFRREG_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜D 腎絲球過濾率自主控制" },
  "stem": "ACEi/ARB 影響腎血流動力，最典型的直接作用部位為何？",
  "options": [
    { "key": "A", "text": "主要使入球小動脈收縮" },
    { "key": "B", "text": "主要使出球小動脈舒張" },
    { "key": "C", "text": "主要使腎小球基底膜增厚" },
    { "key": "D", "text": "主要使腎小球毛細血管收縮" }
  ],
  "answer": "B",
  "explanation": "ACEi/ARB 阻斷 Ang II，最典型使出球小動脈舒張，降低腎小球內壓；在依賴 Ang II 維持 GFR 的狀態可能導致 GFR 明顯下降。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "Apparent mineralocorticoid excess（例如大量甘草）造成的高血壓低血鉀，最符合下列何者？",
  "options": [
    { "key": "A", "text": "高 renin、高 aldosterone" },
    { "key": "B", "text": "低 renin、低 aldosterone" },
    { "key": "C", "text": "低 renin、高 aldosterone" },
    { "key": "D", "text": "高 renin、低 aldosterone" }
  ],
  "answer": "B",
  "explanation": "甘草抑制 11β-HSD2 → 皮質醇活化 MR，表現如 mineralocorticoid 過多但實際 aldosterone 不高；容量擴張使 renin 與 aldosterone 皆低。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "下列何者最符合腎間質疾病相較腎小球疾病的差異？",
  "options": [
    { "key": "A", "text": "更常見大量蛋白尿" },
    { "key": "B", "text": "更常見濃縮功能受損（多尿/夜尿）與輕中度蛋白尿" },
    { "key": "C", "text": "更常見 RBC casts" },
    { "key": "D", "text": "更常見顯著高脂血症" }
  ],
  "answer": "B",
  "explanation": "小管/間質病變常先影響濃縮與酸化功能，蛋白尿通常不如腎小球病變大量；RBC casts 與高脂血症較偏腎小球/nephrotic。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "腎動脈狹窄造成的高血壓最符合哪一種病理生理？",
  "options": [
    { "key": "A", "text": "腎灌流下降→renin 上升→Ang II/aldosterone 上升→血壓上升" },
    { "key": "B", "text": "腎灌流上升→renin 上升→血壓下降" },
    { "key": "C", "text": "完全不經 RAAS" },
    { "key": "D", "text": "只與甲狀腺素相關" }
  ],
  "answer": "A",
  "explanation": "RAS 使腎臟感知灌流不足→RAAS 活化→血管收縮與鈉水滯留→血壓上升（病人可呈現高 renin 狀態，視雙側/單側與另一腎功能而異）。"
},
{
  "id": "MED3_RENAL_INF_ORI_RAS_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜E 腎動脈狹窄（Renal artery stenosis）" },
  "stem": "懷疑腎動脈狹窄時，下列何者較常作為初步非侵入性影像評估工具之一？",
  "options": [
    { "key": "A", "text": "腎動脈多普勒超音波（Doppler ultrasound）" },
    { "key": "B", "text": "胸部 X 光" },
    { "key": "C", "text": "腦部 MRI" },
    { "key": "D", "text": "心電圖" }
  ],
  "answer": "A",
  "explanation": "RAS 初步評估常用 Doppler US；也可用 CTA/MRA 視腎功能與造影風險，確診/介入常以血管攝影為準。"
},
{
  "id": "MED3_RENAL_INF_ORI_TUB_Q0013",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜B 腎小管疾病" },
  "stem": "低血鉀代謝性鹼中毒，若血壓偏低或正常，較支持哪一類原因？",
  "options": [
    { "key": "A", "text": "醛固酮過多或 Liddle" },
    { "key": "B", "text": "利尿劑或 Bartter/Gitelman 等鹽流失性小管病變" },
    { "key": "C", "text": "type 4 RTA" },
    { "key": "D", "text": "DKA" }
  ],
  "answer": "B",
  "explanation": "低鉀鹼中毒若伴高血壓，偏向 mineralocorticoid excess；若血壓正常/低，常見利尿劑、嘔吐或 Bartter/Gitelman 等鹽流失狀態。"
},
{
  "id": "MED3_RENAL_INF_ORI_INTER_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜C 腎間質疾病" },
  "stem": "急性腎盂腎炎的典型臨床表現，下列何者最符合？",
  "options": [
    { "key": "A", "text": "發燒、側腹痛或 CVA tenderness，合併膿尿" },
    { "key": "B", "text": "無發燒但大量蛋白尿與水腫" },
    { "key": "C", "text": "只有肉眼血尿且無任何感染症狀" },
    { "key": "D", "text": "必然無尿" }
  ],
  "answer": "A",
  "explanation": "急性腎盂腎炎常見發燒、寒顫、側腹痛/CVA tenderness，尿液可見白血球與細菌；屬上泌尿道感染。"
},

  {
  "id": "MED3_RENAL_INF_ORI_CKD_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 分期中，Stage 3 的 eGFR 範圍最符合下列何者？",
  "options": [
    { "key": "A", "text": "eGFR ≥90" },
    { "key": "B", "text": "eGFR 60–89" },
    { "key": "C", "text": "eGFR 30–59" },
    { "key": "D", "text": "eGFR <15" }
  ],
  "answer": "C",
  "explanation": "CKD GFR 分期常用：G1 ≥90、G2 60–89、G3 30–59、G4 15–29、G5 <15（mL/min/1.73m²）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 分期中，Stage 4 的 eGFR 範圍最符合下列何者？",
  "options": [
    { "key": "A", "text": "eGFR 45–59" },
    { "key": "B", "text": "eGFR 30–44" },
    { "key": "C", "text": "eGFR 15–29" },
    { "key": "D", "text": "eGFR <15" }
  ],
  "answer": "C",
  "explanation": "Stage 4（G4）對應 eGFR 15–29；是進入末期腎病前的重要準備期（轉介、透析/移植教育與血管通路規劃）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合「CKD 風險分層」除了 eGFR 以外還需納入的關鍵指標？",
  "options": [
    { "key": "A", "text": "血鈉濃度" },
    { "key": "B", "text": "尿蛋白/白蛋白（albuminuria）程度" },
    { "key": "C", "text": "血紅素濃度" },
    { "key": "D", "text": "血小板數量" }
  ],
  "answer": "B",
  "explanation": "CKD 預後與風險評估常用 eGFR（G 分期）搭配 albuminuria（A 分期，如 ACR）共同分層。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "尿白蛋白/肌酸酐比（UACR）最常用於評估下列何者？",
  "options": [
    { "key": "A", "text": "血尿來源" },
    { "key": "B", "text": "蛋白尿/白蛋白尿程度（albuminuria）" },
    { "key": "C", "text": "腎結石成分" },
    { "key": "D", "text": "尿路感染是否存在" }
  ],
  "answer": "B",
  "explanation": "UACR 是評估 albuminuria 的標準化指標，常用於 CKD 風險分層與治療反應追蹤。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者較支持「CKD」而非急性腎損傷（AKI）？",
  "options": [
    { "key": "A", "text": "腎臟超音波顯示雙腎變小、皮質變薄" },
    { "key": "B", "text": "48 小時內肌酸酐上升 0.3 mg/dL" },
    { "key": "C", "text": "近期使用造影劑後肌酸酐上升" },
    { "key": "D", "text": "突發少尿 6 小時" }
  ],
  "answer": "A",
  "explanation": "小腎、皮質變薄等結構性改變支持慢性病程；其餘多偏向 AKI 的時間尺度/誘因。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 的貧血最典型的主要機轉為何？",
  "options": [
    { "key": "A", "text": "骨髓惡性腫瘤" },
    { "key": "B", "text": "腎臟 erythropoietin（EPO）產生不足" },
    { "key": "C", "text": "葉酸過多" },
    { "key": "D", "text": "紅血球破壞增加為唯一原因" }
  ],
  "answer": "B",
  "explanation": "CKD 常見正球性正色素性貧血，核心是 EPO 產生不足；亦可能合併缺鐵、發炎等因素。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合 CKD 相關礦物質骨病（CKD-MBD）的典型趨勢？",
  "options": [
    { "key": "A", "text": "低磷、高鈣、PTH 下降" },
    { "key": "B", "text": "高磷、低鈣、PTH 上升" },
    { "key": "C", "text": "高磷、高鈣、PTH 下降" },
    { "key": "D", "text": "低磷、低鈣、PTH 下降" }
  ],
  "answer": "B",
  "explanation": "腎排磷下降→高磷；活性 Vit D 下降→低鈣；綜合刺激造成次發性副甲狀腺亢進（PTH 上升）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人最常見的酸鹼異常為何？",
  "options": [
    { "key": "A", "text": "代謝性鹼中毒" },
    { "key": "B", "text": "呼吸性鹼中毒" },
    { "key": "C", "text": "代謝性酸中毒（常為 non–anion gap 早期）" },
    { "key": "D", "text": "呼吸性酸中毒必然" }
  ],
  "answer": "C",
  "explanation": "CKD 酸排泄與再生 HCO3− 能力下降，常見代謝性酸中毒（早期可呈高氯性）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0013",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人心血管死亡風險上升的敘述，下列何者正確？",
  "options": [
    { "key": "A", "text": "CKD 與心血管風險無關" },
    { "key": "B", "text": "CKD 是心血管疾病的重要風險因子，風險隨 eGFR 降低與 albuminuria 增加而上升" },
    { "key": "C", "text": "只有 Stage 5 才會增加風險" },
    { "key": "D", "text": "只與血鈉有關" }
  ],
  "answer": "B",
  "explanation": "CKD 會顯著提高動脈粥樣硬化、心衰、心律不整等風險，且與 eGFR/albuminuria 呈階梯式關係。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0014",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人用藥安全，下列何者最正確？",
  "options": [
    { "key": "A", "text": "腎功能不影響藥物半衰期" },
    { "key": "B", "text": "多數腎排除藥物需依 eGFR 調整劑量或給藥間隔" },
    { "key": "C", "text": "只要調整抗生素即可" },
    { "key": "D", "text": "所有止痛藥都安全" }
  ],
  "answer": "B",
  "explanation": "eGFR 下降會使多種藥物/代謝物蓄積，需劑量調整並避免腎毒性藥物。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0015",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者屬於 CKD 病人應盡量避免或謹慎使用的腎毒性藥物類別？",
  "options": [
    { "key": "A", "text": "NSAIDs" },
    { "key": "B", "text": "乙醯胺酚（acetaminophen）適量" },
    { "key": "C", "text": "局部外用乳液" },
    { "key": "D", "text": "生理食鹽水補液（適當使用）" }
  ],
  "answer": "A",
  "explanation": "NSAIDs 可能抑制前列腺素造成入球收縮，並可惡化腎前性灌流狀態或誘發 AKI，CKD 應盡量避免或限縮使用。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0016",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合 CKD 病人常見的體液/電解質問題？",
  "options": [
    { "key": "A", "text": "持續性低血鉀最典型" },
    { "key": "B", "text": "容量過負荷與高血鉀風險增加" },
    { "key": "C", "text": "必然高血鈉" },
    { "key": "D", "text": "必然低血鈣且 PTH 下降" }
  ],
  "answer": "B",
  "explanation": "腎排水排鈉能力下降會導致容量過負荷；排鉀能力下降或 RAAS 抑制用藥會增加高血鉀風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0017",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人若合併 albuminuria，何者最符合延緩腎病惡化的用藥方向？",
  "options": [
    { "key": "A", "text": "優先使用 NSAIDs 控制蛋白尿" },
    { "key": "B", "text": "RAAS 抑制（如 ACEi/ARB）常可降低蛋白尿並延緩惡化（依個案監測肌酸酐/血鉀）" },
    { "key": "C", "text": "一律避免所有降壓藥" },
    { "key": "D", "text": "只要補鈣就可逆轉" }
  ],
  "answer": "B",
  "explanation": "ACEi/ARB 可降低腎小球內壓與蛋白尿，對蛋白尿性 CKD 有腎保護效果，但需監測肌酸酐與血鉀並排除雙側 RAS 等情境。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0018",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 造成尿毒症（uremia）常見症狀，下列何者最典型？",
  "options": [
    { "key": "A", "text": "食慾不振、噁心、疲倦、意識改變或尿毒性心包膜炎" },
    { "key": "B", "text": "必然高熱" },
    { "key": "C", "text": "必然皮疹與嗜酸性球增多" },
    { "key": "D", "text": "只會導致咳嗽" }
  ],
  "answer": "A",
  "explanation": "尿毒症可影響多系統：消化道症狀、神經精神症狀、出血傾向、心包膜炎等；屬於評估透析時機的重要臨床依據。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0019",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列哪一項最能支持需要啟動透析的臨床情境？",
  "options": [
    { "key": "A", "text": "輕度肌酸酐上升但無症狀" },
    { "key": "B", "text": "難以控制的肺水腫或容量過負荷" },
    { "key": "C", "text": "單純輕度蛋白尿" },
    { "key": "D", "text": "血鈉稍低但無症狀" }
  ],
  "answer": "B",
  "explanation": "透析啟動多以症狀/併發症為主（AEIOU 概念延伸）：無法控制的容量過負荷、尿毒症狀、難治高血鉀/酸中毒等。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0020",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人何時應開始進行透析與血管通路（AV fistula）規劃較合適？",
  "options": [
    { "key": "A", "text": "Stage 1 即必須立即建立" },
    { "key": "B", "text": "接近末期腎病（如 eGFR 下降到約 <30 且趨勢惡化）時開始教育/轉介與通路規劃" },
    { "key": "C", "text": "只要有蛋白尿就立即建立" },
    { "key": "D", "text": "等到昏迷才需要規劃" }
  ],
  "answer": "B",
  "explanation": "臨床上常在 G4（eGFR 15–29）前後開始密集準備（依惡化速度與症狀），以避免臨時導管透析。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0021",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者較支持「腎性貧血」的典型血球型態？",
  "options": [
    { "key": "A", "text": "小球性低色素性（microcytic hypochromic）必然" },
    { "key": "B", "text": "正球性正色素性（normocytic normochromic）常見" },
    { "key": "C", "text": "巨球性（macrocytic）必然" },
    { "key": "D", "text": "只有白血球下降" }
  ],
  "answer": "B",
  "explanation": "CKD 貧血典型為 EPO 不足造成的正球性正色素性貧血；若合併缺鐵才可能呈小球性。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0022",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人高血鉀的常見促發因子，下列何者正確？",
  "options": [
    { "key": "A", "text": "ACEi/ARB 或鉀保留型利尿劑使用" },
    { "key": "B", "text": "單純補充維生素 C" },
    { "key": "C", "text": "單純低脂飲食" },
    { "key": "D", "text": "只有運動過多" }
  ],
  "answer": "A",
  "explanation": "CKD 排鉀能力下降時，RAAS 抑制或鉀保留型利尿劑會增加高血鉀風險；另如代謝性酸中毒、組織破壞亦可促發。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0023",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人若出現代謝性酸中毒，最符合的基本治療方向為何？",
  "options": [
    { "key": "A", "text": "常需評估以鹼化治療（如碳酸氫鈉）與找可逆因子" },
    { "key": "B", "text": "一律禁水即可改善" },
    { "key": "C", "text": "只要補鈣即可" },
    { "key": "D", "text": "必然不需處理" }
  ],
  "answer": "A",
  "explanation": "CKD 酸中毒治療多以補充鹼（依嚴重度與個案）並處理誘因；嚴重或合併症狀/難治者可能需透析。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0024",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人常見的鈣磷代謝異常對臨床的重要性，下列何者正確？",
  "options": [
    { "key": "A", "text": "只影響骨頭，與血管無關" },
    { "key": "B", "text": "與骨病變與血管鈣化/心血管風險相關" },
    { "key": "C", "text": "只要補充鐵劑就可解決" },
    { "key": "D", "text": "不需追蹤血磷與 PTH" }
  ],
  "answer": "B",
  "explanation": "CKD-MBD 除骨代謝問題外，也與血管鈣化、心血管事件風險增加有關，因此需系統性監測與處置。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0025",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合 CKD 的評估應包含的基本項目？",
  "options": [
    { "key": "A", "text": "只需追蹤肌酸酐即可" },
    { "key": "B", "text": "eGFR 趨勢、尿蛋白/白蛋白、電解質/酸鹼、血壓與併發症篩檢" },
    { "key": "C", "text": "只要做心電圖即可" },
    { "key": "D", "text": "只要做尿液培養即可" }
  ],
  "answer": "B",
  "explanation": "CKD 需同時評估腎功能趨勢、蛋白尿、可逆/可治因素、心血管風險與併發症（貧血、MBD、酸鹼、鉀、容量）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0026",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "何者最符合「CKD 轉介腎臟科」的常見時機概念？",
  "options": [
    { "key": "A", "text": "任何一次肌酸酐上升 0.1" },
    { "key": "B", "text": "eGFR 顯著下降（如 <30）、快速惡化、重度蛋白尿或不明原因腎病" },
    { "key": "C", "text": "只有感冒才需轉介" },
    { "key": "D", "text": "只要有尿路感染就一定轉介" }
  ],
  "answer": "B",
  "explanation": "常見轉介點：G4（<30）、快速下降、顯著蛋白尿/血尿、難治高血壓、疑遺傳或系統性疾病等，以利準備與延緩惡化。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0027",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人常需要限制哪一項飲食成分以協助控制 CKD-MBD？",
  "options": [
    { "key": "A", "text": "磷攝取" },
    { "key": "B", "text": "維生素 B12" },
    { "key": "C", "text": "水分在所有病人都必須嚴格禁水" },
    { "key": "D", "text": "完全不需飲食調整" }
  ],
  "answer": "A",
  "explanation": "高血磷是 CKD-MBD 核心問題之一；飲食磷控制與（必要時）磷結合劑是常見處置方向。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0028",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人出現水腫與呼吸喘，檢查發現肺水腫。最優先的處置方向通常為何？",
  "options": [
    { "key": "A", "text": "單純限制鹽水、評估利尿與容量管理，必要時升級到超濾/透析" },
    { "key": "B", "text": "只要給抗生素" },
    { "key": "C", "text": "只要給類固醇" },
    { "key": "D", "text": "不需處理，等自然好轉" }
  ],
  "answer": "A",
  "explanation": "容量過負荷是 CKD 常見急症；需優先處理呼吸循環並做容量控制（鹽水限制、利尿、必要時透析/超濾）。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0029",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合「透析啟動」的核心原則？",
  "options": [
    { "key": "A", "text": "只看肌酸酐數字，越高越一定要透析" },
    { "key": "B", "text": "以症狀與難治併發症為主（如高鉀、酸中毒、肺水腫、尿毒症狀），而非單一數值" },
    { "key": "C", "text": "只要 eGFR <60 就透析" },
    { "key": "D", "text": "透析只能在昏迷時才做" }
  ],
  "answer": "B",
  "explanation": "臨床多以症狀/併發症驅動透析決策；eGFR 是參考但不是唯一標準。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0030",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者是 CKD 病人可能出現的尿毒性心包膜炎線索？",
  "options": [
    { "key": "A", "text": "胸痛合併心包摩擦音（pericardial friction rub）" },
    { "key": "B", "text": "單純流鼻水" },
    { "key": "C", "text": "單純腹瀉" },
    { "key": "D", "text": "單純皮膚搔癢且無其他不適" }
  ],
  "answer": "A",
  "explanation": "尿毒性心包膜炎可表現胸痛與摩擦音，屬尿毒症嚴重表現之一，常需評估透析。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0031",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者較符合 CKD 的常見皮膚相關症狀？",
  "options": [
    { "key": "A", "text": "尿毒性搔癢（uremic pruritus）可見" },
    { "key": "B", "text": "必然黃疸" },
    { "key": "C", "text": "必然紫斑症" },
    { "key": "D", "text": "必然水痘樣皮疹" }
  ],
  "answer": "A",
  "explanation": "CKD/透析病人常見尿毒性搔癢，與代謝與炎症因子、鈣磷失衡等多因素相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0032",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者最符合 CKD 病人「血壓控制」在腎保護的臨床概念？",
  "options": [
    { "key": "A", "text": "血壓與腎病進展無關" },
    { "key": "B", "text": "控制血壓可減緩腎功能惡化，尤其蛋白尿性 CKD 常需要更積極的腎保護策略" },
    { "key": "C", "text": "只要血壓正常就不需追蹤腎功能" },
    { "key": "D", "text": "只要吃利尿劑即可，不需其他策略" }
  ],
  "answer": "B",
  "explanation": "高血壓是 CKD 進展的重要可調整因子；血壓控制與降低蛋白尿是延緩惡化的核心方向之一。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0033",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "CKD 病人出現「高磷」時，下列何者較符合常見處置方向？",
  "options": [
    { "key": "A", "text": "增加高磷食物攝取" },
    { "key": "B", "text": "飲食磷限制，必要時使用磷結合劑（phosphate binders）" },
    { "key": "C", "text": "只要補鐵即可" },
    { "key": "D", "text": "不需處理，與預後無關" }
  ],
  "answer": "B",
  "explanation": "高血磷與 CKD-MBD/血管鈣化相關，常見處置為磷限制與（需要時）磷結合劑，並同時調整 Vit D/PTH 策略。"
},
{
  "id": "MED3_RENAL_INF_ORI_CKD_Q0034",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜戊 慢性腎臟病（CKD）" },
  "stem": "下列何者較符合 CKD 病人「高血鉀」的長期管理概念？",
  "options": [
    { "key": "A", "text": "完全不需飲食或用藥調整" },
    { "key": "B", "text": "檢視誘因（藥物/酸中毒/飲食）、調整鉀攝取與用藥，必要時使用降鉀治療並監測" },
    { "key": "C", "text": "只要補鈉就會自動改善" },
    { "key": "D", "text": "只要給退燒藥即可" }
  ],
  "answer": "B",
  "explanation": "長期管理重點是找誘因並做整體調整：飲食鉀、藥物（RAASi/K-sparing）、酸中毒與便祕等；嚴重或難治者需更進階治療/透析評估。"
},

  {
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "慢性血液透析（HD）最理想的長期血管通路為何？",
  "options": [
    { "key": "A", "text": "中心靜脈導管（CVC）" },
    { "key": "B", "text": "動靜脈瘻管（AV fistula）" },
    { "key": "C", "text": "周邊靜脈留置針" },
    { "key": "D", "text": "動脈導管" }
  ],
  "answer": "B",
  "explanation": "AV fistula 長期通暢率較佳、感染與血栓風險較低，通常是 HD 最佳長期血管通路；CVC 多為短期或臨時使用。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "下列何者是中心靜脈導管（CVC）相較 AV fistula 的主要缺點？",
  "options": [
    { "key": "A", "text": "不需要置入手術" },
    { "key": "B", "text": "感染與血栓相關併發症風險較高" },
    { "key": "C", "text": "成熟期較長" },
    { "key": "D", "text": "無法立即使用" }
  ],
  "answer": "B",
  "explanation": "CVC 優點是可立即使用，但缺點是感染、血栓、中心靜脈狹窄等風險較高。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析（HD）主要利用下列哪一種物理機轉清除小分子溶質（如尿素）？",
  "options": [
    { "key": "A", "text": "擴散（diffusion）" },
    { "key": "B", "text": "蒸發（evaporation）" },
    { "key": "C", "text": "沉澱（precipitation）" },
    { "key": "D", "text": "凝固（coagulation）" }
  ],
  "answer": "A",
  "explanation": "HD 主要以半透膜兩側濃度梯度進行擴散清除小分子；水分移除則以超濾（ultrafiltration）為主。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析中的超濾（ultrafiltration）主要用於達成下列何者？",
  "options": [
    { "key": "A", "text": "清除細菌" },
    { "key": "B", "text": "移除水分/控制體液量" },
    { "key": "C", "text": "增加紅血球生成" },
    { "key": "D", "text": "提升補體活性" }
  ],
  "answer": "B",
  "explanation": "超濾是以跨膜壓（TMP）移除水分，達到體液管理與乾體重（dry weight）調整。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "腹膜透析（PD）最典型的主要併發症為何？",
  "options": [
    { "key": "A", "text": "肺栓塞" },
    { "key": "B", "text": "腹膜炎（peritonitis）" },
    { "key": "C", "text": "腦出血" },
    { "key": "D", "text": "甲狀腺風暴" }
  ],
  "answer": "B",
  "explanation": "PD 最典型且重要的併發症是腹膜炎，常見表現為透析液混濁、腹痛、發燒。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 相關腹膜炎最常見的致病菌類型為何？",
  "options": [
    { "key": "A", "text": "革蘭陰性菌（如 Pseudomonas）永遠最多" },
    { "key": "B", "text": "皮膚常在菌的革蘭陽性球菌（如 Staphylococcus spp.）" },
    { "key": "C", "text": "黴菌一定最多" },
    { "key": "D", "text": "結核分枝桿菌一定最多" }
  ],
  "answer": "B",
  "explanation": "PD 腹膜炎常由接觸污染導致，皮膚常在菌的革蘭陽性球菌（如 coagulase-negative staphylococci、S. aureus）常見。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 腹膜炎最具代表性的臨床/透析液表現為何？",
  "options": [
    { "key": "A", "text": "透析液變清澈" },
    { "key": "B", "text": "透析液混濁、腹痛，且透析液白血球上升" },
    { "key": "C", "text": "只有咳嗽" },
    { "key": "D", "text": "只有血壓上升" }
  ],
  "answer": "B",
  "explanation": "PD 腹膜炎典型：透析液混濁（cloudy effluent）、腹痛±發燒，透析液細胞數（WBC）上升且以嗜中性球為主。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析中最常見的急性不適之一為「透析中低血壓」。下列何者最常見相關原因？",
  "options": [
    { "key": "A", "text": "超濾量過大或過快導致血管內容量下降" },
    { "key": "B", "text": "紅血球突然大量生成" },
    { "key": "C", "text": "補體過度上升" },
    { "key": "D", "text": "透析使血鈉必然上升" }
  ],
  "answer": "A",
  "explanation": "透析中低血壓常與超濾速率過高、乾體重設定不當、心臟功能不佳或自律神經障礙等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析失衡症候群（dialysis disequilibrium syndrome）最常見於何種情境？",
  "options": [
    { "key": "A", "text": "長期規律透析且 BUN 很低" },
    { "key": "B", "text": "初次或早期透析、尿素快速下降" },
    { "key": "C", "text": "PD 腹膜炎治療中" },
    { "key": "D", "text": "任何時候都一樣常見" }
  ],
  "answer": "B",
  "explanation": "失衡症候群多見於初次/早期透析時尿素快速降低造成滲透壓梯度→腦水腫風險增加，表現頭痛、噁心、意識改變、抽搐。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人最重要的長期血管通路併發症之一為何？",
  "options": [
    { "key": "A", "text": "AV fistula 狹窄或血栓導致通路失效" },
    { "key": "B", "text": "必然造成肺炎" },
    { "key": "C", "text": "必然造成白血球過低" },
    { "key": "D", "text": "必然造成甲亢" }
  ],
  "answer": "A",
  "explanation": "透析通路常見問題為狹窄/血栓、感染（尤其 graft/CVC），需定期監測（thrill/bruit、透析壓力、血流量等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 相較 HD 的優點之一，下列何者較正確？",
  "options": [
    { "key": "A", "text": "需要每次到透析中心" },
    { "key": "B", "text": "更連續、較溫和的體液移除，血流動力較穩定" },
    { "key": "C", "text": "感染風險必然低於 AV fistula" },
    { "key": "D", "text": "完全不需要自我照護能力" }
  ],
  "answer": "B",
  "explanation": "PD 常被認為較連續且血流動力波動較小；但需要無菌操作與自我照護能力，且腹膜炎是重要風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0012",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人乾體重（dry weight）的概念，下列何者最符合？",
  "options": [
    { "key": "A", "text": "透析後體重越低越好" },
    { "key": "B", "text": "無水腫/無低血壓等容量相關症狀時的目標體重" },
    { "key": "C", "text": "不需要調整，固定不變" },
    { "key": "D", "text": "只由 BMI 決定" }
  ],
  "answer": "B",
  "explanation": "乾體重是估計的「正常容量狀態」體重，用於設定超濾目標；需依血壓、痙攣、肺水腫、下肢水腫等動態調整。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0013",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人為何常建議限制鹽分攝取？",
  "options": [
    { "key": "A", "text": "鹽分會直接破壞腎小球基底膜" },
    { "key": "B", "text": "鹽分增加口渴與水分攝取，導致透析間體重增加與容量過負荷" },
    { "key": "C", "text": "鹽分會讓透析器失效" },
    { "key": "D", "text": "鹽分會讓血鈣必然上升" }
  ],
  "answer": "B",
  "explanation": "限鹽可降低口渴與水分攝取，減少透析間體重增加（IDWG）與容量過負荷/高血壓。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0014",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析中使用 heparin 的主要目的為何？",
  "options": [
    { "key": "A", "text": "治療貧血" },
    { "key": "B", "text": "避免體外循環與透析器凝血" },
    { "key": "C", "text": "降低血鉀" },
    { "key": "D", "text": "提升血鈣" }
  ],
  "answer": "B",
  "explanation": "體外循環容易凝血，常需抗凝（如 heparin）；但有出血風險者需調整策略（低/無 heparin 或區域抗凝）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0015",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "下列何者為透析病人常見的骨礦物質問題與處置方向？",
  "options": [
    { "key": "A", "text": "高磷：以磷限制與磷結合劑為主" },
    { "key": "B", "text": "低磷：必須大量補磷" },
    { "key": "C", "text": "PTH 永遠不需追蹤" },
    { "key": "D", "text": "透析能完全取代腎臟所有內分泌功能" }
  ],
  "answer": "A",
  "explanation": "透析仍常見 CKD-MBD（高磷、PTH 異常等），需飲食/藥物與透析處方共同管理。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0016",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人若出現「通路感染」的警訊，下列何者最符合？",
  "options": [
    { "key": "A", "text": "穿刺點紅腫熱痛或化膿，合併發燒/寒顫" },
    { "key": "B", "text": "只有食慾變好" },
    { "key": "C", "text": "只有皮膚乾燥" },
    { "key": "D", "text": "只有體重下降 0.1 kg" }
  ],
  "answer": "A",
  "explanation": "通路感染可表現局部發炎（erythema、tenderness、drainage）與菌血症症狀（發燒、寒顫），需盡快評估與處置。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0017",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人若透析中出現肌肉痙攣（cramp），最常見相關因素為何？",
  "options": [
    { "key": "A", "text": "超濾過快導致血管內容量下降" },
    { "key": "B", "text": "突然高血鈣" },
    { "key": "C", "text": "突然高血糖" },
    { "key": "D", "text": "補體上升" }
  ],
  "answer": "A",
  "explanation": "透析痙攣常與容量快速移除（高 UF rate）相關，與透析中低血壓常同時出現；需評估乾體重與 UF 設定。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0018",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 的超濾主要仰賴下列何者？",
  "options": [
    { "key": "A", "text": "透析液葡萄糖造成滲透壓梯度" },
    { "key": "B", "text": "透析液的抗生素濃度" },
    { "key": "C", "text": "透析液的血紅素濃度" },
    { "key": "D", "text": "透析液的氧分壓" }
  ],
  "answer": "A",
  "explanation": "PD 以腹膜為半透膜，透析液常以葡萄糖提供滲透壓梯度達到水分移除（超濾）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0019",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "下列何者較不利於選擇腹膜透析（PD）？",
  "options": [
    { "key": "A", "text": "反覆嚴重腹膜炎或腹部手術造成嚴重沾黏" },
    { "key": "B", "text": "希望居家透析" },
    { "key": "C", "text": "血流動力不穩定傾向" },
    { "key": "D", "text": "可配合無菌操作" }
  ],
  "answer": "A",
  "explanation": "嚴重腹腔沾黏、反覆難治腹膜炎、無法自我照護或不適合居家環境等，可能不利 PD。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0020",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人感染 B 型肝炎的風險管理，下列何者最重要？",
  "options": [
    { "key": "A", "text": "不需要任何疫苗" },
    { "key": "B", "text": "疫苗接種與透析單位感染管制（含分區/器材管理）" },
    { "key": "C", "text": "只要吃止痛藥即可預防" },
    { "key": "D", "text": "只要限制蛋白質即可" }
  ],
  "answer": "B",
  "explanation": "透析族群血液暴露機會高，需強化感染管制並建議 HBV 疫苗與抗體追蹤。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0021",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析 adequacy 常用的指標之一為 Kt/V。其最接近的概念為何？",
  "options": [
    { "key": "A", "text": "血紅素與血小板比值" },
    { "key": "B", "text": "尿素清除量相對於體內分布容積的比例" },
    { "key": "C", "text": "腎絲球基底膜厚度" },
    { "key": "D", "text": "血壓波動幅度" }
  ],
  "answer": "B",
  "explanation": "Kt/V 中 K 為清除率、t 為時間、V 為尿素分布容積（約等於總體水），用來評估透析清除充分性。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0022",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "下列何者屬於透析的「急症適應症」常用框架（AEIOU）之一？",
  "options": [
    { "key": "A", "text": "難治高血鉀（Electrolytes）" },
    { "key": "B", "text": "輕微皮膚搔癢" },
    { "key": "C", "text": "輕度蛋白尿" },
    { "key": "D", "text": "單純失眠" }
  ],
  "answer": "A",
  "explanation": "AEIOU：Acidosis、Electrolytes（高鉀）、Intoxications、Overload、Uremia（症狀）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0023",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 病人若出現出口處（exit-site）感染，最可能的表現為何？",
  "options": [
    { "key": "A", "text": "出口處紅腫、分泌物或疼痛" },
    { "key": "B", "text": "只有咳嗽" },
    { "key": "C", "text": "只有血壓上升" },
    { "key": "D", "text": "只有關節痛" }
  ],
  "answer": "A",
  "explanation": "PD catheter exit-site infection 典型為出口處發炎與分泌物，需及早治療以降低隧道感染與腹膜炎風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0024",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析過程中若出現發燒寒顫，最需要優先考慮並處置的危險狀況為何？",
  "options": [
    { "key": "A", "text": "通路相關菌血症（access-related bloodstream infection）" },
    { "key": "B", "text": "單純熱中暑" },
    { "key": "C", "text": "甲狀腺低下" },
    { "key": "D", "text": "偏頭痛" }
  ],
  "answer": "A",
  "explanation": "透析中發燒寒顫須高度懷疑通路感染/菌血症（尤其 CVC），需快速評估、抽培養與給抗生素並處理通路。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0025",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人高血鉀急救中，最立即的心肌保護處置為何？",
  "options": [
    { "key": "A", "text": "口服樹脂" },
    { "key": "B", "text": "胰島素加葡萄糖" },
    { "key": "C", "text": "靜脈注射鈣劑" },
    { "key": "D", "text": "利尿劑" }
  ],
  "answer": "C",
  "explanation": "高血鉀合併心電圖變化時首要是 IV calcium 穩定心肌細胞膜；後續再做鉀轉移（insulin/glucose）與移除（透析等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0026",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人常見的疫苗建議方向，下列何者較正確？",
  "options": [
    { "key": "A", "text": "不需要流感疫苗" },
    { "key": "B", "text": "通常建議包含流感與 B 肝疫苗等（依個案與國家建議）" },
    { "key": "C", "text": "只需要破傷風疫苗" },
    { "key": "D", "text": "疫苗會導致透析失效所以避免" }
  ],
  "answer": "B",
  "explanation": "透析病人感染風險較高，常建議流感、HBV 等疫苗與免疫狀態追蹤（依當地指引）。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0027",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "PD 透析液若發現混濁，最正確的下一步通常為何？",
  "options": [
    { "key": "A", "text": "不理會，等自然變清" },
    { "key": "B", "text": "立即留取透析液檢體（細胞數、培養）並依懷疑腹膜炎處置" },
    { "key": "C", "text": "只做胸部 X 光" },
    { "key": "D", "text": "只要停掉降壓藥即可" }
  ],
  "answer": "B",
  "explanation": "透析液混濁需高度懷疑腹膜炎；應迅速送檢（WBC/分類、Gram stain/培養）並及早開始適當抗生素。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0028",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "血液透析「透析器膜（dialyzer membrane）」的主要功能，下列何者最符合？",
  "options": [
    { "key": "A", "text": "提供半透膜進行溶質擴散與水分超濾" },
    { "key": "B", "text": "製造 EPO" },
    { "key": "C", "text": "合成維生素 D" },
    { "key": "D", "text": "分泌胰島素" }
  ],
  "answer": "A",
  "explanation": "dialyzer 提供半透膜，透過濃度/壓力梯度進行溶質清除與水分移除。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0029",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "下列何者較符合血液透析（HD）與腹膜透析（PD）在生活型態上的差異？",
  "options": [
    { "key": "A", "text": "HD 多為中心定期治療；PD 多可居家執行但需嚴格無菌操作" },
    { "key": "B", "text": "HD 一定比 PD 更自由" },
    { "key": "C", "text": "PD 一定不需要任何訓練" },
    { "key": "D", "text": "兩者完全無差異" }
  ],
  "answer": "A",
  "explanation": "HD 常在透析中心定期進行；PD 可居家（CAPD/APD）但仰賴病人訓練與無菌技術，並需處理出口處照護。"
},
{
  "id": "MED3_RENAL_INF_ORI_DIAL_Q0030",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第一篇 腎內科｜己 透析治療" },
  "stem": "透析病人若出現尿毒性症狀（如噁心、意識改變）且合併難治代謝性酸中毒，最符合的處置方向為何？",
  "options": [
    { "key": "A", "text": "僅給止吐藥即可" },
    { "key": "B", "text": "評估透析（urgent dialysis）或加強透析策略" },
    { "key": "C", "text": "只要補鈣即可" },
    { "key": "D", "text": "完全不需處理" }
  ],
  "answer": "B",
  "explanation": "尿毒症狀與難治酸中毒屬透析重要適應症；需依臨床嚴重度評估緊急或加強透析。"
}
  
]
